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ABSTRACT
KETOMETHYLENE ISOSTERIC AMIDE BOND REPLACEMENTS VIA THE ZINC- 
MEDIATED CHAIN EXTENSION OF N-PROTECTED AMINO ACIDS
by
Cory Theberge 
University of New Hampshire, May, 2002
A methodology for the chain extension of N-protected amino acid P-keto esters to 
y-keto esters utilizing a zinc carbenoid was developed. The reaction was used on amino 
acids containing various protective groups and a variety o f side chain functionality. This 
method was used in the incorporation of ketomethylene isosteric amino acid 
replacements within amino acid sequences. The usefulness of the method on molecules 
supported by a solid phase was explored.
xv
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
INTRODUCTION
Chain Extension Chemistry
The production of y-keto esters has typically been a challenge to chemists. 
Generation of y-keto esters has been accomplished via reactions in which separate 
sources o f ketone and ester functionality are brought together, although these routes are 
often difficult to perform on complex starting materials. 1 Other approaches to y-keto 
esters involve the intermediacy of a cyclopropyl alkoxide, including the work of 
Bieragel, 2 Reissig, 3 Saigo, 4 and Dowd. 5 The zinc-mediated chain extension reaction6 was 
first demonstrated in the conversion of p-keto esters (1) to y-keto esters (3) and most 
likely involves the cyclopropyl alcohol intermediate 2. This procedure is the mildest and 










Scheme 1. The Zinc-Mediated Chain Extension Reaction
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Bieraugels’s Method
The first approach to a y-keto ester which utilized fragmentation o f an 
intermediate cyclopropyl alkoxide equivalent was reported by Bieraugel2 (Scheme 2). 
The enamine ester 4 was prepared from a P-keto ester and reacted with a zinc carbenoid 
prepared according to the method o f Sawada and Inouye. 7 The 2-aminocyclopropane 
ester 5 and the ring opened species 6  were believed to be intermediates in the reaction 
which yielded a y-keto ester in very low yield after hydrolysis.
NRa O EtZnI 
CH2 I2
4
R,N 9  
H
H+
n r 2 h
Scheme 2. Bieraugel’s Cyclopropanation Method
Saieo’s Method
Saigo4 modified Bieraugel’s method by forming the TMS enol ether 7 from a P- 
keto ester and exposing it to Simmons-Smith cyclopropanation conditions (Scheme 3).
™SO O Zn/Cu






D/ ^VV//\ / ^ sQU
a.) KOH/CH3OH 9
O +b.) H30 +
OH
Scheme 3. Saigo’s Cyclopropanation Method
10
The TMS-protected cyclopropyl alcohol intermediate 8  was anticipated, but
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saponification o f the product mixture revealed the formation o f the carboxylic acids 9 and 
10, arising from multiple addition of the carbenoid. Even though yields were favorable, 
none of the desired y-keto products were formed.
Reissig’s Method
Reissig and coworkers3 developed a complementary chain extension reaction 
(Scheme 4) in which the ester was introduced via a [2+l]-cycloaddition o f 
(methoxycarbonyl)-carbenoid derived from methyl diazoacetate to a silyl enol ether 1 1 . 
This route differs from Bieraugel’s and Saigo’s in its disconnection o f the desired 
cyclopropyl intermediate 12. The cyclopropyl ether 12 was fragmented by treatment with 
aqueous acid or fluoride to yield the y-keto ester. The “vicinally donor-acceptor- 
substituted” 8 cyclopropane 1 2  has been demonstrated to be a powerful building block
TMSO j
u
Scheme 4. Reissig’s Cyclopropanation Method
in organic synthesis. Interestingly, simultaneous fragmentation of the cyclopropane and 
formation of a new carbon-carbon bond through treatment with an aldehyde and TiCU 
was shown to stereoselectively yield anti a-substituted y-keto esters 13.9
3
N ,
X y  F ' or
Cu(acac) 2  R R"CHO^
a: X= C 0 2R', Y = H T i C l 4  
b: X= H, Y = COiR'
or"Yoh
. A j y O R *
O13
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Dowd’s Method
A chain extension reaction developed by Dowd and coworkerss utilizes a 
radical-mediated reaction to form y-keto esters (Scheme 5). Treatment o f an ex- 
substituted P-keto ester with a 1 , 1  -dibromoalkane yielded the halide 14. Exposure to
O O][ J[ nBu3SnH














Scheme 5. Dowd’s Cyclopropanation Method
tri-n-butyl tin hydride and an initiator provided the primary radical 15, which added into 
the adjacent ketone carbonyl to give the cyclopropyl radical 16. Fragmentation to the 
ester-stabilized radical 17 and subsequent abstraction of a hydrogen atom from tri-n-butyl 
tin hydride yielded an a-substituted y-keto ester 18. While Dowd’s method proved to be 
useful in the synthesis o f a variety of substituted P-keto esters, it could not be applied to 
a-unsubstituted (R’ = H) substrates, which are readily transformed to side products via 
elimination of the halide in 14. Dowd’s method is nicely complementary to the zinc- 
mediated approach described below, which works poorly with a-substituted P-keto esters.
4
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Zercher’s Method
The most recent chain extension methodology developed by Zercher and 
coworkers utilizes Furakawa-modified Simmons-Smith cyclopropanation conditions. 10 
This one-pot procedure involves the exposure of an a-unsubstituted p- 
keto ester 1  to a zinc carbenoid, forming the proposed cyclopropyl alcohol
Et2Zn












20a R"' = ZnX













R ' J ORt
21 "
Scheme 6 . Mechanism of Zercher’s Zinc-Mediated Chain Extension Reaction
intermediate 2 (Scheme 1). Treatment with mild aqueous acid thus affords the y-keto 
ester 3 in a straightforward manner.
The proposed mechanism of the chain extension reaction (Scheme 5), based on 
analogy to the earlier work o f Bieraugel, 2 Saigo, 3 Reissig, 4  Dowd, 5 and on work done in 
the Zercher research group, 1 1 , 1 2 ,13 involves initial deprotonation of the p-keto substrate 1 
by diethyl zinc or the zinc carbenoid to form the zinc enolate 19. Formation of the 
enolate 19 has been confirmed by its NMR chemical shifts and the presence of 
solubilized ethane gas, a byproduct of enolate formation. 12 Direct alkylation o f the zinc
5
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enolate 19 with ethyl(iodomethyl)zinc gives the organometallic intermediate 20 which 
reacts with the adjacent ketone carbonyl to provide the zinc cyclopropyl alkoxide 2 . 
Evidence for the presence of 20a as an intermediate has been shown through the isolation 
of a-methylated material 2 0 b after the reaction is performed with less than three 
equivalents of diethyl zinc. This result is presumed to be due to the lack of zinc 
counterion stabilization (as in 19) o f the P-keto ester during the reaction. 14 Further 
evidence was shown for the existence of zinc anion 2 0 a when side products were 
observed to be the result of attack o f 2 0 a at the ketone functionality o f the y-keto ester 
products 3 . 15 The zinc cyclopropyl alkoxide intermediate 2 has not been observed during 
NMR studies, 12 presumably due to its rapid fragmentation to the carbon-bound zinc 
intermediate 22. This intermediate is comparable to the dimeric zinc ester enolates found 
in the Reformatsky reaction. 16 Upon addition of aqueous acid to 22, the a-unsubstituted 
y-keto ester 3 is produced.
Scone of the Zinc-M ediated Chain Extension Reaction
In order to demonstrate the utility of the zinc-mediated chain extension reaction, a 
variety of simple P-keto esters 23 were transformed to the corresponding y-keto ester 
products 24 (Table l ) . 6 Alkyl functionality at the a-position of P-keto esters (R’ * H, 
entry i) has led to poor yields and numerous side products, yet cyclopropanation of olefin 
functionality (entries g and h) was demonstrated to be slower than chain extension. The 
exact reasons for the inefficiency of the reaction was unknown, although a rationale based 
upon stability o f the cyclopropyl alkoxide 2 was initially proposed. Specifically, it was
6
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considered that a-substitution would destabilize the cyclopropane and induce
R* O
1 3
entry R R* R” •/•yield 3
a c h 3 H c h 3 81
b c h 3 H C(CH3) 3 72
c CH(CH3) 2 H c h 2c h 3 71
d C(CH3) 3 H c h 3 70
e Ph H c h 2c h 3 75
f CH2CH2Ph H c h 2c h 3 75
8 CH2CH2CH=CH2 H c h 3 74
h CH=CHPh H c h 3 6 8
i c h 3 c h 3 c h 3 23
Table 1. Zinc-Mediated Chain Extension of (3-Keto Esters
fragmentation to the isomeric, and much more nucleophilic, ester enolate 21. Studies to 
modify the reaction conditions identified that a short reaction time ( 2  min) was sufficient 
for minimization o f side products. 17 The instability of the cyclopropyl alkoxide has been 
discounted as a significant factor in the efficiency o f a-substituted chain extension 
reactions however, since NMR studies have shown that the cyclopropane intermediate 
opens quickly in unsubstituted cases as well. It is more likely that the instability o f the 
dimeric species 2 2  plays a role in the lack or reactivity of a-substituted substrates.
An exploration into the chain extension o f simple P-keto phosphonates11 was also 
undertaken to probe its applicability in the preparation of the compounds in Table 2. The
7
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P-keto phosphonates 23 reacted with the zinc carbenoid more slowly than the amide or 
ester reactions, although the typical yield of the chain-extended products 24 was not
?  9  Et2Zn/CH2I2  9  F«V°^
R’ O
23 24
entry R R* R” %  yield 24
a OC(CH3) 3 H c h 2c f 3 NR
b o c h 2c h 3 H c h 2c h 3 NR
c c h 3 H c h 3 85
d c h 3 H c h 2c h 3 69
e Ph H c h 2c h 3 98
f c h 3 CH3 c h 2c h 3 70
e -(CH2)3- c h 2c h 3 82
h c h 2c h 2c h = c h 2 H c h 3 75
Table 2. Zinc-Mediated Chain Extension of P-Keto Phosphonates
diminished. The p-keto phosphonoacetates (entries a and b) proved to be unreactive. The 
presence of a-substitution (R’ in entry f) provided no barrier to efficient reaction, 
although starting materials which contained alkenes(entry h) resulted in the generation of 
cyclopropanated species as unavoidable minor products. Formation of the P-keto 
phosphonate from N-Boc-alanine 25 (Scheme 7) involved the straight-forward 
application of Koskinen’s method. 18 The amino acid-derived substrates 27 reacted well 
under the chain extension conditions. The observation that the chain extension reaction 
proceeded efficiently in the presence of Lewis basic functionality like carbamates
8
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b o c h n ^ A oh  c h 3o h  BoeHN>rX OM# ai*moca&
CH3 MeOH (l H3 n-BuLi
25 26
BocHN^ J L  .POCH3 Et2Zn/CH2I2  BocHN y ^ - ^ P O C H 3
CH, CH2C12  ch  o
C H 3  27 28
Scheme 7. Formation of y-Keto Phosphonate Amino Acid Derivatives
indicated that this method might be applicable to more complex peptidyl systems. The 
successful application o f the chain extension reaction to 27 indicated that the presence of 
the modestly acidic N-H did not deter the zinc-mediated transformation.
X I -  B jf r 'C H A  X  ^  I
CHjClj R 
19 *  30 °
entry R R’ R” % yield 30
a ch3 ch3 ch3 60
b ch3 H Ph 33
c ch3 ch3 Ph 88
d ch3 n-C*H9 n - C ^ 70
e ch3 H H 10
f ch3 H n-CeHi 1 81
e ch3 *(CH2)4- 47
h ch3 H CH2C H C H 2 55
i Ph Bn Bn 42
i t-Bu Bn Bn 60
k Ph ch3 ch3 59
Table 3. Zinc-Mediated Chain Extension of (3-Keto Amides
9
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The conversion of p-keto amides to y-keto amides (Table 3) was also explored. 
When p-keto amides 29 were subjected to the same conditions as P-keto esters, the 
reactions were fast and efficient, and both secondary and tertiary amides underwent clean 
chain extension to 30. When comparing reactions o f the P-keto esters, amides, and 
phosphonates, the relative rates of chain extension appeared to be more consistent with 
rate of complexation of the zinc to the P-keto functionality than with the pKa of the a- 
proton. 19
The lowest yields in the chain extension of the P-keto amides (entries a, b and e) 
were for products which were very water soluble, suggesting a loss of material in the 
aqueous workup. It is interesting to note that the presence of acidic protons (entry b, f, 
and h, and especially e) did not inhibit the reaction. In contrast to the overreactivity o f a- 
substituted P-keto esters 1 , substituents at the alpha position of the P-keto tertiary amides 
inhibited the reaction. The lack of reactivity of the amide substrates was attributed to the 
lowered acidity of the alpha proton, which lies nearly orthogonal to the n-system to 
minimize A(l,3) steric interactions.20
Introduction to Transition State Analogs
Since the initial discussions by Pauling regarding enhanced transition state 
binding between a substrate and an enzyme, medicinal chemists have attempted to apply 
this principle to drug design.21 Wolfenden spearheaded the focus on compounds referred 
to as transition state analogs, which are substances designed to mimic the transition state 
and thereby having the strongest interaction between enzyme and substrate. 22 Features 
found in the active site which stabilize the transition state are also believed to stabilize the
10
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tetrahedral intermediate 32 of peptide bond hydrolysis (Figure 1). Transition state 
analogs for proteases have targeted this tetrahedral intermediate. The tendency for amide
hydrolysis ^
Figure 1. Isosteric Amide Bond Replacements
bonds to undergo hydrolysis (usually enzyme-mediated) has driven the development of 
non-peptidic isosteric replacements of the amide bond in protease inhibitors. 23 Common 
isosteric replacements include the ketomethylene (33), hydroxyethylene (34), and 
difluoroketomethylene (35) groups.
Previous Means of Preparing Ketomethvlene Isosteres
The attractiveness of preparing a peptidomimetic which can be involved in 
hydrogen bonding, yet is not susceptible to hydrolysis has driven the development of the 
ketomethylene isosteric replacement (33, Figure 1) for the peptide amide functionality. 
The ketomethylene unit has been utilized in the development o f inhibitors to a wide 
variety of enzymatic systems, including HIV protease, 24 DJD-carboxypeptidase- 
transpeptidase (final step in bacterial cell wall assembly) , 2 5  aminopeptidase, 26 and snake
11
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venom angiotensin converting enzyme (ACE) , 27 as well as in the generic serine 
proteases. 28
The synthetic challenge of preparing these compounds has previously been met in 
a variety o f ways. One common approach has been to attack an aldehyde (37) with a 
grignard reagent (36, Scheme 8 ). Unfortunately, epimerization of the stereocenter at R” 
is often observed in the formation of the y-hydroxy acid and the oxidation to 38 can
inhibitors, although the grignard reagent was simply derived from 4-bromobut-1 -ene. 
Ester functionality was then incorporated by oxidative cleavage of the olefin. 30
Another method for generation of y-keto ester functionality involves displacement 
o f an a-bromo (or other good leaving group) carbonyl by a malonate or similar stabilized 
enolate. Two variations on this strategy are illustrated in Scheme 9. The first approach 
utilizes an electrophilic ester (40) which is reacted with the salt of a p-keto ester (39). 
Displacement has been reported with optically active substrates (R’ *  H) and results in 
the generation of peptide isosteres with an a-substituent31 The second approach uses a
B rM gv^^/O B n -
36 oxiaauon 38
Scheme 8 . Generation of y-Keto Ester Using a Grignard Reagent
be troublesome. 29 A similar approach was used in the preparation of snake venom ACE
12
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f  l.)NaH
Offlu+ R '^ C 0 2 CH3 2.) TFA
O R'
RA s A r ° c H 3
41 O
c o 2c h 3
0
39
C 0 CH  N aH  
^ C 0 2CH3 
43
40
o  c o 2c h 3 l .N a O C H 3  o  R"
C0 2 CH3c o 2c h 3 2. NaOHNHR'Br NHR'
42 44 45
Scheme 9. Formation of y-Keto Esters via Displacement of a Leaving Group
malonate anion to effect displacement of an activated bromide 42. Alkylation and 
decarboxylation can provide access to a-substituted systems like 45, although the 
challenge of controlling stereochemistry remains. 32
Formation of Transition State Analogs
Of top priority will be the general application of the zinc-mediated chain 
extension reaction to peptide systems in order to develop a general methodology for 
formation of the isosteres described above. The preparation of P-keto ester derivatives of 
a number of N-protected amino acids will be required and the effectiveness of the chain 
extension reaction on these substrates will be tested. Amino acids which contain polar 
groups on the side chains, like aspartic acid, asparagine, serine, and lysine will be utilized 
in a second phase of the study. Furthermore, the zinc-mediated chain extension will be 
attempted on resin-bound p-keto esters as a possible means of generating isosteric amide 
bond replacements on solid supports. Ultimately, the incorporation of a ketomethylene
13
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amide bond isostere in an amino acid sequence will be attempted to test the efficiency of 
the zinc-mediated chain extension reaction in a synthetic sequence.
Human cytomegalovirus (HCMV) is a pathogen recognized as a significant health
of HCMV is dependent on a serine protease, 34 the targeted inhibition of this protease 
presents an attractive strategy for disruption of this virus’ life cycle. The amino acid 
sequence Val-Asp-Ala-Ser has been determined to be necessary for site-specific 
recognition by this serine protease, 35 with cleavage occurring at the Ala-Ser bond. An 
ideal starting point for isosteric amide bond replacement would be at this site. A good 
model of ketomethylene isosteric amide bond replacement using the zinc-mediated chain 
extension reaction would include the Asp-Ala sequence followed by the isostere, then
0  CH, O CH3
Figure 2. Possible Target Molecule Containing Ketomethylene Isostere
an alanine incorporated on the carboxy terminus to demonstrate the possibility of further 
functionalization in that direction. The successful preparation of 46 (Figure 2) would 
demonstrate the applicability o f the zinc-mediated chain  extension reaction to the 
generation of polypeptidyl isosteres.
risk to neonates and immunocompromised patients. 33 Since the replication and assembly
BocHN
O 46
A la  isosteric additional 
amide bond amino acid 
replacement
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DISCUSSION OF RESEARCH
Protected Amino Acid*
A variety of N-protected amino acids were required for this study. Most of the N- 
protected alkyl side-chain containing amino acids 48 (Figure 3) were prepared using 
Schotten-Baumen conditions36 in which aqueous base is used as solvent to capture the 
HC1 expelled by reaction of an amine with an acid chloride or chloroformate. Benzyl
O H O
H’NY Jt'OH N~Pr0 1 eCtj0n P ^ Y ^ O H  
R R
47 48
P = Boc, Cbz, Bz, Fmoc
Boc Cbz Bz Fmoc
Figure 3. Common N-Protective Groups for Amino Acids
chloroformate, benzoyl chloride, and 9-fluorenylmethyl chloroformate were used to form 
the Cbz, 37 Bz, and Fmoc38 protective groups respectively, whereas Boc anhydride was 
used in the installation of a Boc group. 39 For protection with Cbz, it was later found that 
a simple procedure utilizing benzyl chloroformate and dry EtOAc as a solvent worked 
effectively in place of Schotten-Baumen conditions.40
15
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Masamunc-Brooks Reaction
Since a majority of the compounds prepared in this study require p-keto ester 
functionality, a mild and effective means of producing P-keto esters from N-protected 
amino acids was needed.
A standard method for the generation of p-keto esters is through a Claisen 
condensation (Scheme 10). Activation of the carboxylic acid 48 through the acyl
li O 1) activation H 9 9
p V ° h —  p ' N' A A om,
2) ?  R
4g ^ O M e  50
49
Scheme 10. Claisen Reaction
imidazole, 41 acid chloride, 42 or mixed anhydride43 and treatment with an enolate 49 is a 
straightforward means of obtaining P-keto esters 50, yet there was concern about possible 
epimerization of the stereocenter at the R-functionality (the amino acid stereocenter).
It was discovered at an early stage that P-keto ester derivatives of amino acids 
could be consistently produced using the method of Masamune and Brooks (Scheme 
l l ) . 44 In this reaction, the acyl imidazole 51 of the N-protected amino acid 48 is exposed 
to a magnesium salt o f monomethyl malonate, producing the P-keto ester 50 under 
mildly basic conditions. The mechanism is thought to proceed via deprotonation of the 
dimeric species 52 by the equivalent of imidazole left in solution. Subsequent attack of 
53 on the acyl imidazole 51 results in p-keto ester 50 formation.
16
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carbonyl H O O
H O diimidazole H 0  
r N.X0|| (CDD N.X..^ X  °“*
P l  k [ l >  »
48 51 I -C02
V I
w hj VQ v °
M M M + M e O ^ J - s ^ 0  M e O ^ X ^ O  M e O ^ X y .0
Bu2Mg “ *  0  O ---------► Q O "  O Cp
Mg 'Mg Mg
^ ^ U V M A f U  W M M I *  V ^ U W O V
52 53 54
Scheme 11. Mechanism of the Masamume-Brooks Reaction
In the first series o f reactions studied, the racemic N-protected amino acids 48 
were dissolved in THF and treated with carbonyldiimidazole (CDI). Following gas 
evolution, the acylimidazole solution was added to a white slurry of the magnesium salt 
of monomethyl malonate (MMM) in THF formed by mixing a 2:1 ratio of MMM to 
Bu2Mg. When methylene chloride was used as the reaction solvent, the monomethyl 
malonate salt was dissolved completely and the yields of the reactions of FMOC- 
protected amino acids (entries n-q) improved. Typically, the reaction proceeded quickly 
to 40-60% conversion, but lengthy stirring (1-3 days) always improved the yield. The 
completed reaction was partitioned between saturated NH4CI and Et20 . Chromatography 
on silica was necessary to isolate the amino acid-derived P-keto ester 50. The glycine- 
derived products (a, e, j, n) required much more polar solvents for column 
chromatography and were less soluble overall, resulting in decreased yield of purified 
products in these cases.
17
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Table 4 shows the results of the first series of Masamune-Brooks reactions. 
Low yields only occurred (entries g, h, Ic, 1) when the solubility o f the products made
9 l.)CDI/THF 9 |?
N V w  ------------- * P+tNY J ^ O M .
R 2 .) MgBu2/THF r
4 8  monomethyl malonate 5 0
entry 1 2 P R •/•yield 50
a BOC H 91
b BOC Me 70
c BOC Ph 41
d BOC Bn 63
e Cbz H 65
f Cbz Me 6 6
g Cbz iPr 34
h Cbz Ph 45
i Cbz Bn 71
i Bz H 65
k Bz Me 47
1 Bz Ph 28
m Bz Bn 74
n Fmoc H 65
0 Fmoc Me 63
P Fmoc Ph 72
4 Fmoc Bn 64
Table 4. Masamune Brooks Reaction ofN-Protected Amino Acids
column chromatography on silica difficult. Otherwise, the reaction was consistently 
efficient The spectra of the reaction products were compared to literature data of
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material made through alternate methods4 5 and also via the Masamune-Brooks protocol 
(e.g. 50b46).
Masamune-Brooks Reaction Modifications
If further functionalization of 50 was to be accomplished, then a means of 
unmasking the carboxy terminus was necessary. The acidic or basic conditions required 
for saponification of the methyl ester were assumed to be too harsh, since
1.) CPI. THF p h n  U  1 0 J4 M 9 P -H nJ L A . oh
2.) MgBu2, THF X  EtOH r
0 0 R 55 *
H O '^ '^O B n -C 0 2
monobenzyl malonate t Q
("MBM") P -H N ^ Jk
R
57
Scheme 12: Using Monobenzyl Malonate in the Masamune-Brooks Reaction
epimerization of the stereoc enter present in the amino acid was a concern. Monobenzyl 
malonate (MBM) was considered to be a practical alternative to monomethyl malonate in 
the Masamune-Brooks procedure, since the benzyl ester in 55 could be removed by 
hydrogenolysis (Scheme 12), making the carboxylic acid available in 56 for further 
chemistry. When the modified Masamune-Brooks reactions were attempted with 
monobenzyl malonate, an increased solubility of the malonate salt in THF and shortened 
reaction times were observed, no longer necessitating an overnight stir. It is not firmly
19
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established, however, that the increased solubility of the malonate salt is solely 
responsible for the shorter reaction times.
A test hydrogenolysis of the benzyl ester of racemic 55d (R = Bn, P = BOC) 
cleanly gave free (3-carboxylic acid 56d, yet it readily decarboxylated during 
concentration from ethanol (aspirator vacuum, 60°C) to give the methyl ketone 57d (R = 
Bn, P = BOC). Compound 57b (R - Me, P = BOC) was in fact a volatile liquid which 
pumped off under any vacuum greater than that of the aspirator. If care was taken to keep 
56 cool during concentration, 57 was not observed.
Seeking to further expand the Masamune-Brooks protocol, it was thought that use 
of the alanine-derived (3-acid 58 (Scheme 13) in the reaction would offer a direct route to 
compounds such as 59, and subsequent chain extension chemistry could produce the 
ketomethylene isosteric amide bond replacement in 60.
a-) CDI 4 8 — ......... *  P-HN
o  ^ Ph 0  H MX jU U
r  ! I CH2C 12  «  O Vb.) Bu2Mg R M O 'P h
O O tf^rn
OMe
Ph 5 9  0 0




Scheme 13: A Modified Masamune-Brooks Procedure
Preparation of 58 was first accomplished by treating L-alanine methyl ester 61 
with Meldrum’s acid (62, Scheme 14).47 The Masamune-Brooks reactions attempted
20
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
with 58 were unsuccessful, however, and it was speculated that residual Meldrum’s acid 
in 58 (nearly impossible to remove because of its similar solubility and acidity) was
p s  T f  %  o  o
”  X -  “ e0 Y i 'N 'll^ JL'OH
J  ^  reflux o  H
THF or toluene 
61 58
Scheme 14: Use of Meldrum's Acid to form 58
present, perhaps leading to protonation of the magnesium complex 53 (Scheme 11), 
therefore stopping its reaction with the acyl imidazole.
A less direct route (Scheme 15)48 to 58 was conducted in which the acid chloride 
of monobenzyl malonate was reacted with (L)-alanine methyl ester 61 to form the benzyl
0 0 pfj Q Q
a  A ^ Bn Me0 >  U  ( y P d ( C ) M e o ^ NJ ^ 0H
« E10H VNaH 5 3  58
BnBr
^  0  0  " S  o  o
A ~ X oen
° u ^  ° « k " '
Scheme 15. Alternate Formation of Modified Masamune-Brooks Starting Materials
ester 63, which was easily converted to 58 through hydrogenolysis. Decarboxylation was
21
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avoided by removal o f the solvent by rotary evaporation using only very mild heating. 
Since the amide proton o f 58 was also speculated to interfere in the Masamune-Brooks 
reaction, the N-benzyl substrate 6 6  was prepared as well.
Unfortunately, Masamune-Brooks reactions between N-protected amino acids and 
58 or 6 6  were also unsuccessful, indicating that the purity of 58 and 6 6  or the presence of 
the amide proton in 58 were not the cause of interference in the reaction. The reaction 
mixtures were homogenous upon addition of dibutylmagnesium, yet formation of 59 was 
not suggested by TLC or observed after workup and column chromatography.
Substitution at the a-site (R’) of the P-keto ester 69 was also desired in order to 
test the viability of the zinc-mediated chain extension reaction conducted with a- 
substitution present. Formation of these a-substituted P-keto esters 69 was initially 
attempted using a modification of the Claisen-like conditions first reported by Cowan et 
al49  (Scheme 16) in which the enolate of a TMS-ester 67 is reacted with an activated 
carbonyl compound. The trimethylsilyl ester 6 8  could be easily converted to
0 0  ?  U
4g a.) CPI P-HNYJS ^ 'O S iM e J M K M ^ V V ^ O M e
b) OLi R R’ HC1 (anhyd.) R R'
1  6 8  69
|^ O S iM e 3
R* 67
Scheme 16. Approach to a-substituted P-keto esters
the methyl ester with an anhydrous HCl/methanol workup. 50  Unfortunately, the 
imidazole present from the use of CDI in the formation of the acyl imidazole reacted in
22
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
the highly acidic conditions, so neither products 6 8  or 69 could be recovered.
Another approach utilized BF3-etherate in a modification of conditions normally 
used for esterificationsl of carboxylic acids 70 (Scheme 17). It was speculated that a
O a.)BF3(0Et) 2
R ^ O H  b.) MeOH/HCl R 0Me
71
O O
a.) 4 eq. BF^OEtyEtzO P*HNV J L A (
b.) 0 °  R R*
f ^ O S iM e 3 69
R' 67
c.) MeOH/HCl
Scheme 17: Another Approach to a-Substituted P-Keto Esters
BF3-activated carboxylic acid would be susceptible to nucleophilic attack by the enolate 
of TMS-acetate 67. The reactions yielded no detectable amounts o f products and this 
approach was dropped due to the limited reactivity of the N-protected amino acid starting 
materials 48.
The use of a-substituted mono-alkyl malonates in the Masamune-Brooks reaction 
was also explored in the preparation of a-substituted P-keto esters 69 (Scheme 18). In 
the original publication by Masamune and Brooks, 32 it was reported that successful 
neutral C-acylation occurred using a-substituted mono-alkyl malonates and mono-alkyl 
malonate half-thiol esters. Compounds 72a and 72b were prepared in order to generate 
the products 69a and 69b. These reactions were wholly unsuccessful, however, and
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69 a. R' = Me 





73 a. R’ = Me 
b. R' = Bn
72 a. R' -  Me
b. R' = Bn
substituted 
monomethyl malonates
Scheme 18: a-Substituted Mono-Alkyl Malonates in the Masamune-Brooks Reaction
products were barely observable by NMR of the crude reaction mixture. The use of a- 
substituted monobenzyl malonates 73a and 73b was also attempted with no success. 
Variation in temperatures and solvents were screened, but to no effect. Considering the 
problems with these reactions and the previously observed difficulty in chain extending 
a-substituted P-keto esters, the attempts at generating p-keto esters with a-substitution 
were dropped.
The Zinc-Mediated Chain Extension Reaction
The chain extension was initially conducted on the P-keto methyl esters 50 (Table 
5) to test the reaction conditions with a number of different protective groups. The 
reactions were typically performed on a 0.25 to 0.5 mmol scale at 0.04 M concentration 
of carbenoid. The carbenoid was prepared by adding 5.0 eq Et2Zn into a 0 °C solution of 
7.5 eq. CH2I2 in CH2CI2 and stirring 2 min. The 7.5/5.0 ratio o f methylene iodide/diethyl 
zinc was determined to be the most efficient after a series of test reactions were
24
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conducted. The use of five equivalents o f carbenoid generated in this manner shortened
ZnEt2/CH2 l2  p - H N ^ J L ^ ^ O M e
OMe r T T
CH2CI2  R O
50 74
entry P R */• yield 74
a Boc H 25
b Boc Me 48
c Boc Ph 57
d Boc Bn 49
e Cbz H 60
f Cbz Me 60
g Cbz iPr 77
h Cbz Ph 48
i Cbz Bn 6 8
j Bz H 58
k Bz Me 58
1 Bz Ph 43
m Bz Bn 58
n Fmoc H 55
0 Fmoc Me 57
P Fmoc Ph 63
4 Fmoc Bn 6 8
Table 5. Chain Extension Reactions of Amino Acid-Derived p-Keto Esters
reaction times and minimized the appearance of side products. Reactions that utilized 
three or four equivalents of carbenoid often showed traces of residual starting material, 
presumably due to the quenching o f a small portion of the carbenoid by traces of water
P-HN
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
contained in the solvent or starting material. Additionally, excess methylene iodide 
eliminated the possibility of free diethyl zinc in solution which could behave as a 
nucleophile or as a base and facilitate the generation of side products. The use of an 8 /S 
or 1 0 /S ratio of methylene iodide/diethyl zinc only seemed to increase the amount of 
methylene iodide present after workup and did not improve the yield of y-keto ester.
After formation of the carbenoid, the ice bath was removed and a CH2CI2 solution 
of the starting P-keto ester was added rapidly. The reaction was monitored by normal 
phase TLC until complete, with product (74) spots appearing at a slightly lower fy  than 
starting materials in all of the reactions. Visualization of product formation was much 
easier with anisaldehyde stain, as the product and starting material spots appeared as 
different colors.
The reaction was often complete within IS minutes and never took more than an 
hour at room temperature. When the reaction was complete, it is washed with saturated 
NH4CI solution, dried with MgS0 4 , and concentrated. The crude material was 
chromatographed on silica using EtOAc in hexane. Competitive side product formation 
seemed to occur with the Boc-glycine substrate 50a, but a five minute reaction time 
minimized side product formation (at a cost to yield). Glycine-based products were less 
soluble in organic solvents and required more polar solvents for chromatography (50% 
EtOAc/hexane was typical). Various spectra of the products were confirmed by 
comparison to literature sources. 53
After these initial reactions were performed, we addressed the concern that 
epimerization might be occurring in the Masamune-Brooks and/or chain extension 
reactions. Since a convenient method for the determination o f optical purity was
26
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
o(L H M  a.) CPI B^ N ^ t ^ ^ E t ^ C H A ^ Y ^ V 08" 
(Boc-L-Phe) b.) MBM, I S5d CH2C12  ph/  ?5d 0
MgBu2  THF ^
80%ec 80%ee
5% H20/MeOH 5% H20/MeOH
Scheme 19: Racemization Occurring in Phenylalanine Series
needed, chiral HPLC was selected for the analysis of the y-keto ester products from 
reactions with enantiomerically pure starting materials. Both a D,L mixture and a single 
enantiomer of the Boc-L-phenylalanine-derived Masamune-Brooks product (55d) and 
chain extension product 75d were prepared and compared on a Daicel Chiralpak® AD- 
RH reverse phase chiral column (Scheme 19). The benzyl esters were selected for use 
with the UV-vis detector. The phenylalanine derivatives S5d and 75d readily separated 
using 5% H20/MeOH and it was observed that 10% racemization occurred during the
0  0  y
BocHN. __   .OBn
a H S b  a .) CPI Bo c H N ^ J l ^ A fa,- Et^ ii.C H 2l j
(Boc-L-Ala) b.) MBM, £ ^  CH2 Cl2  '  O
MgBu2, THF i ) t f a  87.5% ee
2.) Cbz-Cl 20% H20/M e0H
Et3N 
O O
CbzHN J U L . _ • « * «  
i 5 5 f  100% MeOH
Scheme 20: Racemization Occurring in Alanine Series
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formation of the Masamune-Brooks products (giving an 80% ee). Most significantly, 
there was no further racemization noted during the chain extension reaction.
Separation of the Boc-alanine Masamune-Brooks product 55b was not possible 
using various ratios o f acetonitrile/water and methanol/water, so it was converted to the 
Cbz-protected analog 55f, which separated well using 100% MeOH (Scheme 20). Again 
racemization was noted in the Masamune-Brooks product 55f, but no further 
racemization was noted in the chain extension product 75d.
O 0
a.) CDI , Et2Zn, CH2I2  BzHN(L H 8 1
(Bz-L-PheGly)b.)MMM, * CH2C12  ph - 4 |  ft
MgBu2 THF 5 0 1
10% H20/MeOH 10% H2 0/MeOH
1 0 0 % racemized
Scheme 21: Racemization Occurring in Phenylglycine Series
With phenylglycine, the only effective separation was obtained using the benzoyl 
(Bz) protected Masamune-Brooks methyl ester product 5 0 1 (Scheme 21). hi this case, 
complete racemization occurred during the Masamune-Brooks reaction to give racemic 
501. No information on racemization during the chain extension reaction to form 741 
could thus be attained.
A couple of other observations were noted when using the Daicel Chiralpak® 
AD-RH reverse phase chiral column (Figure 4). The racemic Cbz-phenylglycine 
Masamune-Brooks product 50h readily separated with 10% H20/MeOH, but compounds 
like 76 (analogous to 63) appeared to be far too lipophilic for the column, indicating that
28
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the carbamate linkage facilitates easy separation of enantiomers on the reverse-phase 
Daicel column.
A further test of stereochemical integrity was conducted as in Scheme 22. The p- 
keto ester 55b (87% ee, per Scheme 20) derived from Boc-L-alanine was subjected to 
chain extension conditions to give 75b. The carboxylic acid 77b, obtained by 
hydrogenolysis, was then coupled to the L-phenylalanine methyl ester 61. As expected, 
no decarboxylation of y-keto esters 75 occured as observed with the P-keto esters 55, 
even with mild heating of the acid 77 during concentration from ethanol. No 
epimerization of the stereoc enters was observed in the product 78, as only one
CbzHN
50 h 76
Figure 4: Additional Compounds Studied by Chiral HPLC
n  O O u
BOCHISJ A  1.) CDI, THF B o c H N ^ A A  ZnEt2, CH2 I2  BocHN OBn
Y ^ 0H 2 .) MBM, r I CH2 C12  - O
'  «CK naa/ 75b79%
EDC, HOBt 
Et,N, DMFBocHN BocHN
Scheme 22: Formation of an Isosteric Replacement
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diastereomer was present by NMR. It should be noted that the chromatographic 
separation of 78 may have contributed to its diastereomeric purity through separation of 
the minor diastereomer. The high mass recovery of 78 suggested that the minor 
diastereomer was present only in trace quantities, if  at all.
indicate that N-methylation has the potential to be a competing reaction when zinc 
carbenoids are present (Scheme 23). A systematic survey of functionality at this
Scheme 23: Potential N-Methylation Side Products in the Chain Extension Reaction
nitrogen, which included amide, Boc, Cbz, and FMOC derivatives revealed no trace of N- 
methylated chain extended side products 79.
Different Side Chain Attempts
In addition to the alkyl side chains, a study of amino acid derivatives with polar 
side chains (Table 6 ) was undertaken. Since acidic protons would hinder the Masamune- 
Brooks and could potentially affect the chain extension reactions, protection of the side 
chains was required. The serine, aspartic acid and lysine residues were thus masked with 
protective groups, while the asparagine side chain was left intact, since primary amide 
functionality has been shown to be tolerated by the chain extension reaction. 36 The
Reports in the literature34 and unpublished observations from our laboratory33
50 79
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entry R P Conf. % yield 55 •/• yield 75
r OBn-Asp Boc D.L 74 55
s OBn-Asp Boc L 72 60
t N-Boc-Lys Boc D,L 50 69
a N-Boc-Lys Boc L 57 77
v Asn Boc D,L 0 (15% of80y* -
w OBn-Ser Boc DX 75 < 1 0
X OBn-Ser Boc L 72 < 1 0
(♦see text)
Table 6: Polar Side-Chain Functionality
O-benzyl aspartate and Boc-lysine derivatives 55r-u and 75r-u were easily formed, while 
problems occurred with the asparagine and O-benzyl serine series. The Masamune- 
Brooks reactions of the asparagine substrates provided only a small yield of the product 
80 containing a dehydrated asparagine side chain. The poor solubility of the asparagine 
derivatives in THF contributed to a longer reaction time, and the small amount of desired 
product formed was immediately converted to the dehydrated material under Masamune- 
Brooks conditions. Chain extension reactions to form 75v have not been attempted. The 
O-benzyl serine Masamune-Brooks products 55w and 55x formed easily, but many side 
products were observed in the chain extension reaction. It was difficult to determine the
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structures o f these side products, but they appeared to have a low molecular weight, 
indicating a significant decomposition of the starting material under chain extension 
conditions.
The integrity of the stereocenter during the Masamune-Brooks and chain 
extension reactions was tested on the di-Boc-L-lysine substrates 55a and 75a using the 
aforementioned Daicel Chiralpak® AD-RH reverse phase chiral column. Both were 
readily separable using 10% HzO/MeOH and, as before, 10% of the Masamune-Brooks 
product 55a was racemized, whereas no additional racemization was noted after the chain 
extension reaction to form 75u.
Ketomethylene Isostere via the Chain Extension Methodology
In order to test the applicability o f the chain extension methodology to actual 
synthetic examples, an analogue of a potential inhibitor57 of human cytomegalovirus 
(HCMV) protease 8 6  was constructed in which the cleavage site between the alanine and 
serine residues was replaced with a ketomethylene isosteric amide bond replacement 
(Scheme 25). Following DCC coupling of Boc-L-asparagine L-48u to the benzyl ester of 
L-alanine to form the dipeptide 81, the carboxylic acid 82 was cleanly unmasked by 
hydrogeno lysis. The acid was then subjected to Masamune-Brooks conditions to form 
the P-keto ester 83. Initially the reaction to form the dipeptide 81 appeared to occur in 
very low yields, but it was discovered that the isolated material was in fact the nonpolar 
nitrile side product resulting from DCC-induced dehydration of the asparagine side chain 
residue. The nitrile 80 was easily recognizable by its unique 13C NMR resonance at
32
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@116 ppm. Formation of the insoluble and highly polar asparagine-containing product 
81 was not detected until more polar TLC solvent systems were utilized.
O
Scheme 24. Side Product Resulting from Dehydration of Asparagine Side-Chain
It should be noted that all of the products in this synthesis, starting with 81, 
exhibit poor solubility in standard low boiling solvents, including THF, MeOH, CH2CI2 
and Et20 . This posed a problem initially, as the Masamune-Brooks and chain extension 
reactions were typically run in THF and CH2CI2, respectively. It was discovered (out of 
necessity) that the acyl imidazole intermediate of the Masamune-Brooks reaction could 
be formed in DMF and then added to the preformed magnesium malonate complex in 
THF. The use o f DMF as a solvent did not appear to noticeably inhibit the reaction here, 
even though previously attempted Masamune-Brooks reactions on Boc-asparagine using 
DMF as the solvent resulted in dehydration of the asparagine side chain as with 55v.
The chain extension reaction was conducted by adding solid 83 directly to the 
preformed zinc carbenoid in CH2CI2 . Formation of y-keto ester 84 was extremely rapid 
after addition of starting material and the reaction ran very cleanly, but column 
chromatography was conducted on 84 in order to rid the product of any residual zinc salts 
and methylene iodide. Flash chromatography of the amino acid derivatives in Scheme 25
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Scheme 25. Formation of Ketomethylene Isosteric Amide Bond Replacement
on silica was limited to MeOH/CH2Cl2 solvent systems, as the insolubility and polarity of 
the derivatives due to the presence of asparagine prevented the use of EtOAc/hexane. To 
this end, flash chromatography was only conducted on 84 and 8 6  to m inim ize the loss of 
material. All of the other products were purified by aqueous extraction of leftover 
reagents, followed by recrystallization.
After hydrogenolysis of the benzyl ester in 84 to form 85, the final amino acid 
residue was coupled with DCC to the methyl ester of L-alanine to complete the sequence 
to 8 6 . Yields were very good in all of the steps, further demonstrating the applicability of
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the zinc-mediated chain extension reaction toward the generation of ketomethylene 
isosteric amide bond replacements.
Application to Solid Phase Combinatorial Chemistry
Most solid phase peptide chemistry58 involves binding the amino acid to the 
support through the carboxylate and building the peptide chain toward the N terminus. 
This is done to minimize both racemization of the stereocenter and oxazolidinone 
formation. A simple system needed to be constructed to see whether the zinc-mediated 
chain extension reaction was useful around polystyrene resins and their associated linkers. 
Retrosynthetically, the easiest way to build a simple system analogous to the examples 
studied herein and perform the chain extension on a solid support would be to bind the 
nitrogen end of the amino acid to the resin and construct a (3-keto ester from the carboxy 
terminus. The benzyl carbamate linker of the Wang59 resin was not expected to inhibit 
the reaction.
Towards this end, the N-terminus of an amino acid was attached to a Wang resin 
using previously reported chemistry. 60 hi this procedure (Scheme 26), the Wang resin 
was activated through treatment with p-nitrophenyl chloroformate to give 87. 
Displacement of the p-nitrophenyl group with allyl-protected L-phenylalanine was 
accomplished in DMF with Hunig’s base added to free the amine from its salt form. The 
allyl ester of 8 8  was transformed to the free acid 89 by treatment with palladium(O) and 
morpholine in THF. A Masamune-Brooks reaction on the acid proceeded very cleanly to 
give the (3-keto ester 90. The P-keto ester formation was dependent on treatment of the 
resin-bound acid with a significant excess o f GDI and thorough washing of the acyl
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Scheme 26: Attempted Solid Phase Synthesis
imidazole with THF before exposure to the magnesium/malonate complex in THF. 
Quenching the reaction with 5% AcOH/THF and rinsing the resin thoroughly with SO/SO 
water/THF effectively provided the resin-bound P-keto ester. After each of these steps, a 
sample of the dried resin was treated with CH2CI2/TFA and the product TFA salt weighed 
to determine the resin loading. Analysis o f the cleaved material by NMR indicated that 
all of the reactions to this point occurred cleanly. The loading of the material on the resin 
did not significantly decrease in any of the steps, indicating cleavage of material from the
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resin was not occurring in the reactions, hi each step, only clean products were obtained 
after cleavage.
Although many variations in library assembly could be envisioned from a resin- 
bound P-keto ester, we were primarily interested in exploring the compatibility of the 
chain extension method with the resin-bound P-keto ester. The chain extension 
methodology allows for the general incorporation of a methylene unit in the individual 
compounds. Following cleavage from the resin, large varieties of inhibitor analogs with 
isosteric amide bond replacements can be created in only a fraction of the steps currently 
necessary.
The resin-bound P-keto ester 90 was exposed to chain extension reaction 
conditions that used variations in reaction times, concentrations of carbenoid, and 
quenching methods, but, unfortunately, none of the chain extended product 91 was 
isolated. In fact, very little material was recovered at all from the resin after the chain 
extension reaction, leading to the speculation that the zinc carbenoid solution is simply 
too harsh an environment for the resin to withstand. Extensive washing of the resin was 
conducted after the reaction in order to rule out the possibility o f zinc salts “clogging” the 
resin, but no product was recovered. The resin was also exposed to the carbenoid for less 
than one minute to see if some starting material could be recovered, but none was visible 
after cleavage from the resin. The reaction was also quenched in a variety of ways, 
including the use of 5% AcOH in CH2CI2, SO/SO water/THF, and addition of a saturated 
ammonium chloride solution to the resin suspended in CH2CI2 . Finally, the resin-bound 
amino acid 89 was treated briefly with carbenoid and quenched with 5% ACOH/CH2CI2 
before thoroughly rinsing and drying the resin. No material was isolated after attempted
37
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cleavage of resin-bound products, leading to the conclusion that the carbenoid is in fact 
cleaving the substrate from the resin before chain extension is occurring.
The lack of success in these attempts leads us to believe that the Wang resin may 
not be appropriate for use in the zinc-mediated chain extension reaction. It is possible 
that a carboxy-terminus bound amino acid-based P-keto substrate might be more 
appropriate when using the zinc-mediated chain extension on solid supports.
Conclusions
The zinc-mediated chain extension reaction has been demonstrated to be of 
practical synthetic utility in the construction of N-protected amino acid-derived y-keto 
esters from P-keto esters. With a variety of alkyl side chain functionality, as in alanine, 
phenylalanine, and phenylglycine, the reaction proceeded without significant production 
of side products. However, the yields were only marginal if the starting material or 
products were especially insoluble or otherwise difficult to purify.
Amino acids with protected non-alkyl side chains like aspartic acid and lysine 
underwent chain extension without incident, yet serine derivatives appeared to markedly 
decompose in the presence of the zinc carbenoid. Asparagine, with its primary amide 
side chain functionality was not easily converted to a P-keto ester substrate, since its 
solubility in the solvents used for this transformation was limited. If the asparagine side 
chain was separated from the carboxy terminus by an amino acid containing an alkyl side 
chain (such as alanine), the solubility of the molecule was sufficient for both the the 
Masamune-Brooks and chain extension reactions.
The amino acid stereocenters of alanine and phenylalanine are epimerized
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slightly during the production of the P-keto ester substrates, yet further epimerization is 
not observed during the zinc-mediated chain extension reaction, indicating that the 
reaction has a promising future in the chain extension o f substrates which contain 
stereocenters.
The incorporation of a ketomethylene isosteric amide bond replacement in 
tripeptide- and tetrapeptide-analogues was easily accomplished using the zinc-mediated 
chain extension reaction. The synthesis of these molecules proceeded without noticeable 
epimerizadon of the am ino acid stereocenters and even worked well in the presence of the 
asparagine side chain, which inhibited the Masamune-Brooks and chain extension 
reactions of Boc-asparagine.
The chain extension of resin-bound P-keto esters to y-keto esters was not 
successful even after a variety of conditions and workups were attempted. This 
disappointing result seems to occur through actual physical damage of the resin by the 
zinc carbenoid. Alternative linkers, including carboxy-bound amino acid supports, 
should be investigated for their suitability in facilitating solid phase chemistry. 
Fortunately, the vast majority of amino acid syntheses on solid supports is accomplished 
through attachment of the carboxy terminus to the resin and construction outward toward 
the N-terminus, so the zinc-mediated chain extension may prove to be of some utility in 
solid phase synthesis in the future.
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EXPERIMENTAL
General Experimental
All reactions were run in oven-dried glassware under nitrogen atmosphere and stirred 
with teflon-coated magnetic stir-bars. The terms concentrated in vacuo or under reduced 
pressure refer to the use of a rotary-evaporator. Methylene chloride was distilled from 
phosphorous pentoxide. Ethyl acetate and hexanes were distilled prior to use. Reagents 
were purchased from commercial suppliers and used without further purification. Diethyl 
zinc was used as a 1 . 0  M solution in hexanes. Methylene iodide (CH2I2) was purchased 
from commercial suppliers and non-oxidized copper wire was added as a stabilizer. 
Column chromatography was performed on EM Science flash silica gel (35-75pm). 
Mobile phases were used as noted. Thin Layer Chromatography (TLC) was carried out on 
EM Science F2S4 glass plates and visualized by UV and anisaldehyde or 
phosphomolybdic acid stains. The {^values were determined with the same solvent used 
for column chromatography. Low Resolution Mass Spectroscopy was performed by the 
University o f New Hampshire Instrumentation Center on a Perkin-Elmer 2400 Analyzer. 
High Resolution Mass Spectroscopy was performed at Merck Pharmaceutical Research, 
West Point, PA. NMR spectroscopy was performed on a Broker AM360.
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Representative Procedures and Data
Formation of the 0-Keto Methyl Ester (Masamune-Brooks procedure)
Methyl 4-(carbobenzyloxy)amino-3-oxo-5-phenyl-pentanoate (50i)
Into a 25 mL round-bottomed flask equipped with a stir bar were placed 300 mg (1.00 
mmol) Cbz-phenyalanine (481) and 10 mL anhydrous THF. Carbonyl diimidazole (CDI) 
(178 mg, 1.10 mmol) was added and the solution stirred until gas evolution ceased 
(approximately IS minutes). In a separate 100 mL round-bottom flask which contained a 
solution of monomethyl malonate (352 mg, 3.00 mmol) in 30 mL of anhydrous THF was 
added 1 .SO mL (1.S0 mmol) of a 1M hexane solution of dibutylmagnesium at 0 °C. This 
solution, which appears as a white slurry, was allowed to warm to room temperature. The 
acyl imidazole solution was transferred in one portion to the flask which contained the 
magnesium salt and the reaction was monitored by TLC. The solution was allowed to 
stir for 48 hours and quenched by the addition of 30 mL sat. aq. NH4CI solution. The 
solution was extracted three times with 20 mL EtjO. The combined organics were dried 
with MgS04, filtered, and concentrated. The crude residue was chromatographed on 
silica with 15% EtOAc in hexanes to yield 252 mg (71%) of 50i as a colorless oil: *H 
NMR (360 MHz, CDCI3) 8  7.39-7.23 (m, 8 H), 7.15 (m, 2H), 5.35 (d, 1H, J = 7.7 Hz), 
5.12 (s, 2H), 4.67 (m, 1H), 3.70 (s, 3H), 3.55-3.43 (m, 2H), 3.19-3.14 (dd, 1H, J=  6.1,
14.0 Hz), 3.04-2.98 (dd, 1H, J = 7.1,14.0 Hz); l3C NMR (90 MHz, CDCI3) 8  201.6,
167.3,155.8,136.2, 135.8,129.2,128.8,128.5,128.2,128.1, 127.2,67.1,60.8,52.4,
46.7,36.9. HRMS (M +Naf calculated 378.1312, found 378.1305 for C ^ iN iO sN a .
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Methyl 4-(carboxy-t-butyl)-amino-3-oxo-butanoate (50a)
91 %, yellow oil; lH NMR (360 MHz, CDC13) 8  5.22 (bs, IH), 4.11 (d, 2H, 7 =  5.1 Hz), 
3.72 (s, 3H), 3.49 (s, 2H), 1.43 (s, 9H); l3C NMR (90 MHz, CDC13) 8  198.6, 167.0,
155.6.80.1.52.5.50.5.46.2.28.2.
(±)-Methyl 4-{carboxy-t-butyl)-amino-3-oxo-pentanoate (50b)
70 %, white soUd; mp = 52-54 °C: lH NMR (360 MHz, CDC13) 8  5.15 (bs, 1H), 4.36 (dq, 
1H, > 7 .0 ,7 .0  Hz), 3.73 (s, 3H), 3.50 (d, 1H, 7 =  15.7), 3.40 (d, 1H, 7 =  20.0), 1.43 (s, 
9H), 1.36 (d, 3H, 7 =  7.0 Hz); 13C NMR (90 MHz, CDCI3) 8  202.3,167.5,155.3,80.0,
55.3.52.4.45.5.28.2. 16.9.
(±)-Methyl 4-(carboxy-t-butyl)-ainiiio-3-oxo-4-phenylbutanoate (50c)
41%, colorless oil; lH NMR (360 MHz, CDCU) 8  7.54-7.29 (m, 5H), 5.82 (bs, 1H), 5.44 
(m, 1H), 3.65 (s, 3H), 3.48 (d, 1H, 7 =  16.0 Hz), 3.33 (d, IH, 7 =  16.0 Hz) 1.40 (s, 9H); 
l3C NMR (90 MHz, CDCI3) 8  198.3,166.6, 154.7,135.7,129.3,128.8, 128.1,80.1,64.4,
52.4.45.8.28.2. HRMS (M+Na)+ calculated 330.1312, found 330.1314 for 
CisHiiNiOsNa.
(±)-Methyl 4-(carboxy-t-butyl)-anilno-3-oxo-5-phenylpentanoate (50d)
63%, white solid; mp = 78 -  79 °C: lH NMR (360 MHz, CDCI3) 8  7.33-7.16 (m, 5H),
5.02 (m, IH), 4.56 (dt, IH, 7=7.2,7.2Hz), 3.71 (s, 3H), 3.52 (d, IH, 7 =  16.0 Hz), 3.46 (d, 
IH, 7 =  16.0 Hz), 3.14 (d, 1 ,7=  14.0 Hz), 2.97 (d, IH, 7 =  14.0), 1.40 (s, 9H); 13C NMR
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(90 MHz, CDCI3) 8  201.8,167.3,155.2,136.0,129.2,128.7,127.0, 80.2,60.4, 52.4,
46.6.36.9.28.2. HRMS (M+H)+ calculated 322.1649, found 322.1668 for Ci7H24Nl0 5.
Methyl 4-(carboxybenzyl)-aniino-3-oxo-butanoate (50e)
65%, yellow oil; lH NMR (360 MHz, CDCI3) 8  7.36 (m, 5H), 5.41 (bs, IH), 5.13 (s, 2H), 
4.22 (d, 2H, 7 =  5.0 Hz), 3.75 (s, 3H), 3.51 (s, 2H); ,3C NMR (90 MHz, CDCI3) 8  198.3,
166.7.156.2, 136.2,128.5,128.2, 128.1,67.1, 52.6,50.8,46.2.
(±)-Methyl 4-(carboxybenzyl>aniino-3-oxo-pentanoate (501)
6 6 %, yellow oil; lH NMR (360 MHz, CDCI3) 8  7.39-7.26 (m, 5H), 5.72 (d, IH, 7 =  7.1 
Hz), 5.08 (s, 2H), 4.40 (s, IH), 3.68 (s, 3H), 3.60-3.47 (m, 2H), 1.33 (d, 3H, 7 =  7.1 Hz); 
l3C NMR (90 MHz, CDCI3) 5 202.0, 167.3, 155.8,136.2, 128.5,128.2, 128.0,67.0,55.8,
52.4,45.5, 16.8.
(±>Methyl 4-(carboxybenzyl)-amino-5-methyl-3-oxobexanoate (50g)
34%, colorless oil; lH NMR (360 MHz, CDC13) 8  7.37-7.30 (m, 5H), 5.36 (d, IH, 7 =  8.7 
Hz), 5.12 (s, 2H), 4.42 (dd, IH, 7 =  3.9, 8.7 Hz), 3.71 (s, 3H), 3.55 (bs, IH), 2.27-2.20 
(m, IH), 1.02 (d, 3H, 7 =  6 . 8  Hz), 0.80 (d, 3H, 7 =  6 . 8  Hz); I3C NMR (90 MHz, CDCI3)
8  201.7,167.2,156.6, 136.6,128.7,128.4,128.3,67.4,65.0,52.6,47.1,29.8,20.0,16.7.
(±)-Methyl 4-(carboxybenzyl>amino-3-oxo-4-phenylbutanoate (50h)
45%, colorless oU; lH NMR (360 MHz, CDCI3) 8  7.38-7.26 (m, 10H), 6.14 (bs, IH), 5.52
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(m, 1 H), 5.13-5.00 (m, 2H), 3.66 (s, 3H), 3.49 (d, IH, 7 =  12.1 Hz), 3.34 (d, IH, 7 =
12.0); l3C NMR (90 MHz, CDC13) 6  197.7, 166.5, 155.2, 136.0, 135.3, 129.4, 129.4,
129.0,128.5,128.1, 128.1,67.1,64.6,52.5,45.7. HRMS (M+Na)+ calculated 364.1155, 
found 364.1171 for CigH^NiOsNa.
(±)-Methyl 4-<carboxybenzyl)-aniino-3-oxo-5-phenylpentanoate (500
71%, colorless oil; 'H  NMR (360 MHz, CDClj) 8  7.39-7.23 (m, 8 H), 7.15 (m, 2H), 5.35 
(d, IH, 7  = 7.7 Hz), 5.12 (s, 2H), 4.67 (dd, IH, 7 =  7.0,13.8 Hz), 3.70 (s, 3H), 3.55-3.43 
(AB, 2H ,7=  16 Hz), 3.17 (dd, 1H ,7= 6 .1 ,14.1 Hz), 3.01 (dd, 1H ,7 = 6 .0 ,14.1 Hz); l3C 
NMR (90 MHz, CDCI3) 8  201.6,167.3, 155.8,136.2, 135.8,129.2, 128.8, 128.5,128.2,
128.1,127.2,67.1,60.8, 52.4,46.7,36.9. HRMS (M+Na)+ calculated 378.1312, found 
378.1305 forC 20H2 ,NiOsNa.
Methyl 4-(N-benzoyl)-aniino-3-oxo-butanoate (50j)
65%, Ideal solvent for flash chromatography is 30% acetone in hexane. White solid; mp = 
83 -  8 6  °C: 'H NMR (360 MHz, CDClj) 8  7.83 (m, 2H), 7.55-7.43 (m, 3H), 6.93 (bs,
IH), 4.47 (d, 2H, 7 =  4.7 Hz), 3.76 (s, 3H), 3.59 (s, 2H); I3C NMR (90 MHz, CDClj)
8  198.1, 167.3,166.9,133.5,131.9,128.6,127.1,52.6,49.9,46.5.
(±)-Methyl 4-(N-benzoyI>amino-3-oxo-pentanoate (501t)
47%, colorless oil; lH NMR (360 MHz, CDCI3) 8  7.80-7.76 (m, 2H), 7.52-7.38 (m, 3H), 
7.11 (d, IH, 7 =  6.5 Hz), 4.85 (m, IH), 3.70 (s, 3H), 3.66 (d, IH, 7 =  15.6 Hz), 3.60 (d,
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IH, J  = 15.0 Hz), 1.41 (d, 3H, J=  7.3 Hz); l3C NMR (90 MHz, CDC13) 8  201.9, 167.3,
166.9.133.5, 131.8,128.6, 127.0, 54.7,52.5,45.7,16.8.
(±)-Methyl 4-(N-benzoyl)-ainino-3-oxo-4-phenylbutanoate (501)
28%, colorless oil; lH NMR (360 MHz, CDCI3) 8  7.81 (bs, IH), 7.52-7.33 (m, 10H), 5.90 
(d, IH, 7 =  6.1Hz), 3.67 (s, 3H), 3.53 (d, IH, 7 = 15.4 Hz), 3.43 (d, IH, 7 =  15.4 Hz); l3C 
NMR(90MHz,CDCl3)8  198.3, 166.5,166.3, 135.3,133.5,131.8, 129.4, 129.0, 128.5,
128.3.127.1.63.5, 52.5,45.9. HRMS (M+H)+ calculated 334.1046, found 334.1050 for 
C 18H 18N1O4 .
(±)-Methyl 4-(N-benzoyl)-ainlno-3-oxo-5-phenylpentanoate (50m)
74%, colorless oil; lH NMR (360 MHz, CDCh) 8  7.69 (m, 2H), 7.51 (m, IH), 7.39 (m, 
2H), 7.32-7.19 (m, 5H), 6.87 (d, IH, 7 =  7.2 Hz), 5.10 (dt, IH, 7 =  6.9,7.2 Hz), 3.69 (s, 
3H), 3.60 (d, IH, 7  = 15.8 Hz), 3.52 (d, IH, 7 =  15.7), 3.28 (dd, IH, 7 =  6.4,14.1 Hz),
3.16 (dd, 1H, 7=6.3 ,14.0  Hz); 13CN M R(90MHz,CDC13)8  201.2, 167.2, 167.1,135.8,
133.4, 131.9,129.2, 128.8, 128.6, 127.2,127.0,59.6,52.4,46.8, 36.6. HRMS (M+Na)+ 
calculated 348.1206, found 348.1211 for Ci9Hl9N 10 4Na.
Methyl 4-(carboxy-9-fluorenylmethyl>amino-3-oxo-butanoate (50n)
65%, white soUd; mp = 115-117 °C: lH NMR (360 MHz, CDCI3) 8  7.77 (m, 2H), 7.59 
(m, 2H), 7.42-7.29 (m, 4H), 5.63 (m, IH), 4.44 (m, 2H), 4.21 (m, 3H), 3.73 (s, 3H), 3.49 
(s, 2H); I3C NMR (90 MHz, CDCI3) 8  198.3,167.1,156^, 143.7,141.3,127.7,127.1,
125.0,120.0,67.1,52.6,50.8,47.1,46.2.
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(±)-Methyl 4-(carboxy-9-fluorenylmethyI)-amino-3-oxo-peiitanoate (SOo)
76%, white solid; mp = 105 -1 0 7  °C: 'H  NMR (360 MHz, CD Cl3) 8 7.77 (m, 2H), 7.59 
(m, 2H), 7.42-7.29 (m, 4H), 5.52 (bs, IH), 4.48-4.38 (m, 3H), 4.23-4.19 (m, IH), 3.73 (s, 
3H), 3.55 (m, 2H), 1.39 (d, 3H, 7 =  7.0 Hz); l3C NMR (90 MHz, CDCI3) 8 202.1,167.0,
155.8, 143.7,141.3,127.7, 127.1, 125.0,120.0,66.9, 55.8,52.5,47.1,45.5, 17.0.
(±)-Methyl 4-(carboxy-9-fluorenylmethyl)-ainino-3-oxo-4-phenylbatanoate (50p)
85%, white solid mp. 139 -  142 °C: lH NMR (360 MHz, CDCI3) 8 7.77-7.75 (m, 2H), 
7.58-7.56 (m, 2H), 7.42-7.26 (m, 9H), 6.16 (d, IH, J  = 5.7 Hz), 5.54 (d, IH, J=  6.3 Hz), 
4.42-4.30 (m, 2H), 4.21-4.18 (m, IH), 3.68 (s, 3H), 3.52 (d, IH, J = 16.0 Hz), 3.46 (d, 
1H,7= 16.0 Hz); 13C NMR (90 MHz, CDCI3) 8 197.8, 166.4,155.2, 143.8, 141.2, 135.3,
129.4,129.1, 128.1, 127.7,127.0,125.0, 119.9,67.1,64.6,52.5,47.1,45.7.
(±)-Methyl 4-(carboxy-9-fluorenylmethyl)-aiiiiiio-3-oxo-5-phenylpentanoate (50q)
67%, white solid; mp = 75 -  78 °C: 'H  NMR (360 MHz, CDC13) 8 7.78 (m, 2H), 7.55 (m, 
2H), 7.42 (m, 2H), 7.31-7.24 (m, 5H), 7.16 (m, 2H), 5.48 (d, IH, J=  7.8 Hz), 4.67 (dt,
IH, J = 7.6, 7.8 Hz), 4.46-4.38 (m, 2H), 4.20-4.15 (m, IH), 3.71 (s, 3H), 3.52 (d, IH, J=
16.0 Hz), 3.46 (d, IH, J = 16.0 Hz), 3.19 (A of AB, IH, J=  6.0,14.0 Hz), 3.00 (B of AB, 
IH, / =  7.5,14.0 Hz); 13C NMR (90 MHz, CDCI3) 8 201.4,167.2,155.8,143.7,141.3,
135.9,129.3,128.8,127.8,127.2,127.1,125.0,120.0,66.9,60.8,52.5,47.2,46.6,36.7. 
HRMS (M +H f calculated 466.1625, found 466.1617 for C ^ H ^ O sN a .
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Formation of the (J-Keto Benzyl Ester (Masamune-Brooks procedure using 
monobenzyl malonate) 
Monobenzyl Malonate
Into a 2S0 mL round-bottomed flask was added 25 g (173 mmol) 2,2-dimethyl-1,3- 
dioxane-4,6-dione, 35 mL (337 mmol) benzyl alcohol, and 100 mL toluene. The reaction 
was heated for 24 h at 106 °C before it was concentrated to approximately one half of its 
initial volume on the rotary evaporator. The concentrated mixture was partitioned 
between 200 mL Et20  and 350 mL 5% Na2C0 3  and the aqueous portion washed twice 
more with 100 mL Et2 O. The aqueous layer was then acidified to pH -  2 with 1M HC1 
and then extracted with 3 X 150 mL EtOAc. The combined EtOAc extracts were dried 
with MgS0 4  and concentrated to a viscous oil which was pumped for 2 h at high vacuum. 
Crystallization of the oil was affected by the addition of a small amount of dry THF and 
the resultant material pumped for 2 h to remove any further moisture or solvent to yield 
17.5 g (52%) pure monobenzyl malonate as a white solid; lH NMR (360 MHz, CDCI3)
8  7.43-7.32 (m, 5H), 5.22 (s, 2H), 3.49 (s, 2H).
Benzyl (4S)-4-(carboxy-t-butyl)-amino-3-oxo-p*nUnoate (55b)
Boc-L-alanine L-48b (176 mg, 0.93 mmol) was dissolved in 10 mL anhydrous THF in a 
25 mL round-bottomed flask and 154 mg (0.95 mmol) of CDI added while stirring, hi a 
separate 100 mL flask monobenzyl malonate (722 mg, 3.72 mmol) was dissolved in 30 
mL anhydrous THF and 1.86 mL (1.86 mmol) of a 1M solution of dibutylmagnesium was 
added at 0 °C. The reaction was allowed to warm to room temperature (solution is
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colorless and clear). After gas evolution was complete (IS min), the acyl imidazole was 
transferred to the magnesium malonate solution. The reaction was monitored by TLC and 
quenched after 24h by addition of 30 mL sat aq. NH4CI solution. The solution was 
extracted three times with 20 mL Et2 0  and the combined organic layers were dried with 
MgS04, filtered, and concentrated. The residue was chromatographed on silica with 15% 
EtOAc in hexanes to yield 208 mg (70%) 55b as a colorless oil: 'H  NMR (360 MHz, 
CDClj) 6  7.38-7.31 (m, 5H), 5.18 (s, 2H), 5.08 (s, IH), 4.36 (m, IH), 3.66-3.56 (m, 2H), 
1.44 (s, 9H), 1.33 (d, 3H, J=  7.1 Hz); l3C NMR (90 MHz, CDClj) 8  202.4,166.4,155.5,
135.0,128.6,128.4,128.3, 79.8,67.2, 55.4,45.7,28.2,16.8. HRMS (M+Na)+ calculated
344.1468, found 344.1464 forCnH^NiOs.
Benzyl (4S)-4-[(tei1-butoxycarbonyI)amino]-3-oxo-4-plienylbutanoate (55c)
71%, colorless oil: ‘H NMR (360 MHz, CDClj) 8  7.39-7.27 (m, 10H), 5.82 (s, IH), 5.45 
(d, lH , /=  5.9 Hz), 5.19 (m, IH), 5.10 (s, IH), 3.52 (d, IH ,J=  15.8 Hz), 3.39 (d, 1H,7= 
15.8 Hz), 1.41 (s, 9H); l3C NMR (90 MHz, CDClj) 8  198.1,166.1, 154.5,135.8,135.0,
129.3,128.8,128.5,128.3, 128.1, 128.0,80.2,67.2,64.4,45.9,28.2.
Benzyl (4S)-4-[(tert-butoxycarbonyl)amino]-3-oxo-5-phenylpentanoate (55d)
82%, colorless oil: lH NMR (360 MHz, CDClj) 8  7.42-7.13 (m, 10H), 5.16 (m, 2H), 4.97 
(d, IH, J  = 6.5 Hz), 4.55 (dt, IH, J=  7.0,7.0 Hz), 3.56 (d, IH, J=  16.1 Hz), 3.49 (d, IH, 
J=  16.0 Hz), 3.14 (dd, IH, J =  5.9,13.9 Hz), 2.95 (dd, IH, J=  5.8,13.8 Hz), 1.39 (s,
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9H); I3C NMR (90 MHz, CDCI3) 8  201.8,166.7,155.2,136.0,135.2,129.2,128.7,
128.6,128.5,128.4,127.0,80.2,67.2,60.5,46.8,36.9,28.2.
Dibenzyl (3S)-3-[(tert-butoxycarbonyI)amino]-4-oxohexanedioate (55r)
74%, colorless oil: lH NMR (360 MHz, CDCI3) 6  7.39-7.33 (m, 10H), 5.60 (d, IH, 7=
8.9 Hz), 5.17 (m, 2H), 5.11 (s, 2H), 4.59 (m, IH), 3.68 (s, 2H), 3.04 (dd, IH, 7 =  5.0,17.4 
Hz), 2.81 (dd, IH, 7 =  5.2,18.0 Hz), 1.45 (s, 9H); 13C NM R(90 MHz, CDC13) 8  201.4,
171.3,166.4, 155.5, 135.2, 135.2, 128.6, 128.6,128.4, 128.4, 128.2, 128.2,80.8,67.2,
66.9, 56.0,45.8,35.3,28.2.
Benzyl (4S)-4,8-bis[(tert-butoxycarbonyI)amino]-3-oxooctanoate (55u)
57%, colorless oil: *H NMR (360 MHz, CDCI3) 8  7.37 (m, 5H), 5.16-5.20 (m, 2H), 4.56 
(bs, IH), 4.30 (m, IH), 3.64 (d, IH, 7 =  16.0 Hz), 3.57 (d, IH, 7 =  15.8 Hz), 3.08 (m, 2H), 
1.84 (m, 2H), 1.60-1.28 (m, 6 H), 1.44 (s, 18H); ,3C NMR (90 MHz, CDCI3) 8  207.8,
166.7, 156.2, 155.8, 135.3, 128.6, 128.5,128.4,80.1,79.5,67.2, 59.5,46.1,39.7,30.3,
29.6,28.4,28.3,22.2.
Benzyl (4S)-5-(benzyloxy)-4-[(tert-batoxycarbonyI)amlno]-3-oxopentanoate (55w)
75%, colorless oil: lH NMR (360 MHz, CDCb) 8  7.41-7.25 (m, 10H), 5.50 (d, IH, 7 =
7.2 Hz), 5.16 (s, 2H), 4.47 (m, 2H), 3.90 (m, IH), 3.65 (m, 2H), 1.45 (s, 9H); 13C NMR 
(90 MHz, CDCI3) 8  200.4, 166.6,155.5,137.0, 135.5,128.6, 128.5, 128.3, 127.9,127.7,
80.5,73.4,69.3,67.1,59.8,46.7,28.3.
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ferf-Butyl (lS)-l-benzyl-2-oxopropylcarbamate (57d)
'H NMR (360 MHz, CDC13) 6 7.38-7.15 (m, 5H), 5.54 (m, IH), 5.11 (m, IH), 3.13-2.96 
(m, 2H), 2.13 (s, 3H), 1.42 (s, 9H).
3-{[(lS)-l-Beiizyl-2-methoxy-2-oxoethyl]aiiiino}-3-oxopropanoic acid (58)
Into a 25 mL round bottom flask charged with 10 mL absolute ethanol and 400 mg (1.12 
mmol) 63 is added 20 mg of 10 wt% palladium on activated carbon. The flask is charged 
twice with nitrogen and twice with hydrogen and kept under a hydrogen atmosphere 
while monitoring by TLC until complete (3h). The flask is flushed with nitrogen and the 
reaction Altered through a 0.45 uM syringe Alter before concentrating to yield 248 mg 
(83%) 58; lH NMR (360 MHz, CDCI3) 6 7.55 (m, IH), 7.28-7.09 (m, 5H), 4.85 (q, IH, J  
= 6.5,13.4 Hz), 3.70 (s, 3H), 3.31 (s, 2H), 3.15 (dd, IH, J=  5.7,13.9 Hz), 3.09 (dd, IH, J  
= 5.8,14.0 Hz); I3C NMR (90 MHz, CDCI3) 8 171.7, 170.0, 167.4,135.5,129.2, 128.6,
127.2, 53.7,52.5,39.3,37.6.
Methyl N-[3-(benzyloxy)-3-oxopropanoyl]-L-phenyIaIaninate (63)
Into a 50 mL round-bottomed flask charged with 20 mL toluene was added 1.46 g (7.54 
mmol) monobenzyl malonate and 5 mL oxalyl chloride. The mixture was stirred 
overnight and then concentrated to give 1.60 g of monobenzyl malonyl chloride as a 
viscous yellow oil. The acid chloride was dissolved in 10 mL CH2CI2 and added to a 
solution of 1.62 g (7.54 mmol) L-phenylalanine methyl ester hydrochloride in 40 mL 
CH2CI2 and the solution cooled to 0 °C before adding 1.00 mL triethylamine slowly 
dropwise. The reaction was stirred for 15 minutes and then diluted with 50 mL CH2CI2
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before washing with SO mL sat aq. NH4CI, SO mL sat N aH C03 and 30 mL H2O. The 
organic portion was dried with MgSO< and concentrated under reduced pressure. Flash 
chromatography on silica using 30% EtOAc in hexanes yielded 1.82 g (70 %) 63; lH 
NMR (360 MHz, CDCI3) 8  7.38-7.24 (m, iOH), 7.11 (m, IH), 5.16 (s, 2H), 4.88 (dd, IH, 
J=  5.9,13.6 Hz), 3.72 (s, 3H), 3.35 (s, 2H), 3.15 (dd, IH, J =  6.1,14.2 Hz), 3.09 (dd, IH, 
7 =  6 .0 , 14.2 Hz); I3C NMR (90 MHz, CDCI3) 5 170.3,166.9, 166.7, 137.8,135.4,
129.4, 128.7,128.4, 127.8,127.2, 126.7,62.2, 53.0, 52.2,41.5.
Methyl N-benzyl-L-phenylalaniDate (64)
Into a 100 mL round-bottomed flask was added 1.23 g (6.87 mmol) L-phenylalanine 
methyl ester 61 and the flask charged with 35 mL anhydrous DMF. The flask was cooled 
to 0 °C and 274 mg (6.87 mmol) of a 60% dispersion of NaH in mineral oil added in 
small portions. After stirring vigorously for 10 min, benzyl bromide (763 uL, 6.18 mmol) 
was added slowly dropwise and the reaction monitored by TLC until complete (<15 
minutes). The reaction was diluted with 40 mL sat aq. NH4CI solution and 50 mL Et2 0  
and the organic layer was separated and washed with 2 x 20 mL H2O. The organic 
portion was dried with MgS( > 4  and concentrated under reduced pressure. Flash 
chromatography on silica using 20% EtOAc in hexanes yielded 1.30 g (70 %) methyl N- 
benzyl-L-phenylalaninate 64 as a colorless oil. 'H  NMR (360 MHz, CDCI3) 8  7.35-7.12 
(m, 10H), 3.80 (d, IH, .M 3.2  Hz), 3.65 (s, 3H), 3.64 (d, IH, / =  13.0 Hz), 3.55 (m, IH), 
2.94 (d, 2H, J = 13.5 Hz); l3C NMR (90 MHz, CDCI3) 8  175.0, 139.5,137.3,129.2,
128.3,128.2,128.1,127.0,126.6,62.0,51.9,51.6,39.7.
51
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Methyl N-benzyl-N-[3-(benzyloxy)-3-oxopropanoyI]-L-plienylalaninate (65)
Into a 25 mL round-bottomed flask charged with 10 mL toluene was added 440 mg (2.23 
mmol) monobenzyl malonate and 2 mL oxalyl chloride. The mixture was stirred 
overnight and then concentrated to give 480 mg of monobenzyl malonyl chloride as a 
viscous yellow oil. The acid chloride was dissolved in 5 mL CH2CI2  and added to a 
solution of 610 mg (2.23 mmol) methyl N-benzyl-L-phenylalaninate in 1 0  mL CH2CI2 . 
The solution is cooled to 0 °C and triethylamine (300 uL, 2.23 mmol) is added slowly 
dropwise. The reaction was stirred for 15 minutes and then diluted with 30 mL CH2CI2 
before washing with 30 mL sat. aq. NH4CI, 30 mL sat. NaHC0 3  and 30 mL H2O. The 
organic portion was dried with MgS04 and concentrated under reduced pressure. Flash 
chromatography on silica using 20% EtOAc in hexanes yielded 600 mg (75 %) methyl N- 
benzyl-N-[3-(benzyloxy)-3-oxopropanoyl]-L-phenylalaninate 65 as a colorless oil; ‘H 
NMR (360 MHz, CDC13) 6  7.38-7.05 (m, 15H), 5.19 (s, 2H), 4.42 (1H, A of AB, J=  17.0 
Hz), 4.33 (dd, IH ,J=  5.8,9.1 Hz), 3.85 (IH, B of A B ,J=  16.9 Hz), 3.62 (s, 3H), 3.51- 
3.25 (m, 3H), 3.22-3.18 (m, IH); l3C NMR (90 MHz, CDC13) 8  170.3,166.9, 166.7,
137.8,135.4,129.4,129.2, 128.7,128.6, 128.4, 127.8,127.2, 126.7,67.2,61.4, 52.9,
52.1,41.5,35.1.
3-{Benzyl[(lS)-l-benzyl-2-methoxy-2-oxoethyl]ainino}-3-oxopropanoic acid (66)
Into a 25 mL round-bottomed flask containing 360 mg (1.10 mmol) methyl N-benzyl-N- 
[3-(benzyloxy)-3-oxopropanoyl]-L-phenylalaninate 65 and charged with 5 mL absolute 
ethanol was added 300 mg of 10 wt% palladium on activated carbon and 960 ul (11.00 
mol) 1 ,4-cyclohexadiene. The solution was stirred 3h and filtered through a 0.45 uM
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syringe filter before concentrating and chromatographing on silica using 8 S/1 S CH2CI2- 
/10% NH4 OH in MeOH to yield 240 mg (85%) 3-{benzyl[( 1 S> 1 -benzyl-2-mcthoxy-2- 
oxoethyl]amino}-3-oxopropanoic acid 6 6  as a white solid; 'H  NMR (360 MHz, CDCI3)
8  7.27-7.06 (m, 10H), 5.70 (s, IH), 4.47 (1H, A of AB, J=  16.7 Hz), 4.30 (m, IH), 3.87 
(IH, B of AB, J =  16.5 Hz), 3.60 (s, 3H), 3.39-3.20 (m, 3H), 3.20-3.14 (m, IH); 13C 
NMR (90 MHz, CDCI3) 8 171.0,169.8, 167.5,137.2, 133.9,129.0, 128.9,128.8, 128.3,
127.1,127.0,62.1, 52.6, 52.6,36.2,34.9.
Zinc-mediated Chain Extension Reaction General Experimental Procedure -  
Methyl Esters 
Methyl 5-(carbobenzyloxy)amino-4-oxo-6-phenyl-hexanoate (741)
A 50 mL round-bottomed flask was charged with 30 mL anhydrous CH2CI2 and 255 uL 
(3.16 mmol) of methylene iodide added. The solution was cooled to 0 °C and 2.11 mL 
(2.11 mmol) of a 1M solution of diethylzinc in hexanes was added slowly. The ice bath 
was removed immediately and a white precipitate formed rapidly. After stirring for two 
minutes, a 5 mL CH2CI2 solution of 150 mg (0.42 mmol) 50i was added and the reaction 
monitored by TLC (normal phase). The product spot appeared at a slightly higher R/  
than starting material and was best visualized by staining the TLC plates with 
anisaldehyde. The reaction was complete after 30 min and was quenched with 25 mL sat 
aq. NH4CI solution. The organic solution was dried with MgS(>4 , filtered, and evaporated 
under reduced pressure. Flash chromatography on silica using 15 % EtOAc in hexane 
provided 106 mg (6 8 %) of 74i as a colorless oil: lH NMR (360 MHz, CDCI3) 8  7.38-7.14
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(1X1, 10H), 5.38 (d, 1H, J=  7.3 Hz), 5.08 (s, 2H), 4.64 (dd, IH, J=  6 . 6  Hz), 3.67 (s, 3H),
3.16 (dd, IH, J  = 6.4,14.1), 2.99 (dd, IH, J=  6.9,14.1), 2.81-2.74 (m, 2H), 2.60-2.57 (m, 
2H); l3C NMR (90 MHz, CDC13) 8  207.0, 173.0,156.0,136.2, 135.9, 129.2, 128.7,
128.5, 128.2,128.1, 127.1,66.9,60.5,51.8,37.4,35.1,27.5. HRMS (M+Naf calculated
392.1468, found 392.1477 for C2 iH23N 10 5Na.
Zinc-mediated Chain Extension Reaction General Experimental Procedure -  Benzyl 
Esters 
Phenylmethyl (5S)-5-(carboxy-t-butyl)-amino-4-oxo-hexanoate (75b)
A 50 mL round-bottomed flask was charged with 30 mL anhydrous CH2CI2 and 375 uL 
(4.67 mmol) methylene iodide and cooled to 0 °C. A1M solution of diethylzinc in 
hexanes (3.11 mL, 3.11 mmol) was added slowly. The ice bath was removed and a white 
precipitate formed rapidly. After stirring 2 min, 200 mg (0.62 mmol) of 55b dissolved in 
5 mL CH2CI2 was added and the reaction monitored by TLC. The product spot appeared 
at a slightly higher R/  than starting material and was best visualized by staining the TLC 
plates with anisaldehyde. The reaction was complete after 30 min and was washed with 
25 mL sat. aq. NH4 CI solution before drying with MgS0 4  and concentrating. Flash 
chromatography on silica using 15 % EtOAc in hexane yielded 164 mg (79 %) of 75b as 
a colorless oil: ‘H NMR (360 MHz, CDC13) 8  7.39-7.29 (m, 5H), 5.18 (m, IH), 5.11 (s, 
2H), 4.33 (m, IH), 2.92-2.62 (m, 4H), 1.44 (s, 9H), 1.33 (d, 3H, J =  7.1 Hz); l3C NMR 
(90 MHz, CDCI3) 8  207.9, 172.3, 155.5,135.7,128.5, 128.3,128.2, 79.8,66.5,55.0,
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33.6,28.3,27.8, 17.6. HRMS (M+Na)+ calculated 358.1625, found 358.1599 for
CigHyNiOsNa.
Methyl 5-(carboxy-t-butyl)-amino-4-oxo-pentanoate (74a)
(reaction time 5 minutes) 25%, colorless oil; 'H NMR S (360 MHz, CDCh) 5.21 (bs,
IH), 4.06 (m, 2H), 3.67 (s, 3H), 2.74-2.62 (m, 4H), 1.43 (s, 9H); l3C NMR (90 MHz, 
CDCI3) 6  204.2,172.8,155.6,79.8,51.8,50.2,34.3,28.2,27.5.
(±)-Methyl 5-(carboxy-t-butyl)-amino-4-oxo-hexanoate (74b)
48%, colorless oil; lH NMR (360 MHz, CDCI3) S 5.21 (bs, IH), 4.34 (dt, IH, 7 =  6.2,6.2 
Hz), 3.68 (s, 3H), 2.91-2.56 (m, 4H), 1.44 (s, 9H), 1.36 (d, 3H, 7 =  6.2 Hz); l3C NMR (90 
MHz, CDCh) 6  207.8, 173.2, 155.1, 79.9,55.0, 51.8.33.6,28.3,27.5,17.7.
(±)-Methyl 5-(carboxy-t-butyl)-amino-4-oxo-5-phenylpentanoate (74c)
57%, colorless oil; ‘H NMR (360 MHz, CDCI3) 5 7.40-7.30 (m, 5H), 5.86 (bs, IH), 5.33 
(d, IH, 7 =  5.4 Hz), 3.65 (s, 3H), 2.81-2.46 (m, 4H), 1.40 (s, 9H); l3C NMR (90 MHz, 
CDCI3) 6  204.3, 172.6, 154.8,136.8, 129.1,128.5, 127.8,79.9,64.1,51.8,34.3,28.2,
27.6. HRMS (M +Naf calculated 322.1648, found 322.1655 for C n H ^ O sN a .
(±)-Methyl 5-(carboxy-t-butyl)-ainino-4-oxo-6-phenylhexanoate (74d)
49%, colorless oil; lH NMR (360 MHz, CDC13) 6  7.33-7.25 (m, 4H), 7.19 (m, IH), 5.05 
(bs, IH), 4.54 (m, IH), 3.68 (s, 3H), 3.16-3.10 (AX, IH, 7 =  7.1,14.0 Hz), 2.98-2.93 
(BX, IH, 7 =  7.0,13.9 Hz), 2.78-2.69 (m, 2H), 2.60-2.56 (m, 2H), 1.40 (s, 9H); 13C NMR
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(90 MHz, CDCI3) 8  207.4, 172.9,155.1,136.2, 129.2, 128.6,126.9, 80.0,60.1, 51.8,
37.5,35.1,28.2,27.5. HRMS (M+Na)+ calculated 358.1625, found 358.1635 for 
CigHyNjOsNa.
Methyl 5-(carboxybenzyl>-amino-4-oxo-pentanoate (74e)
60%, colorless oil; lH NMR (360 MHz, CDCI3) 8  7.36-7.30 (m, 5H), 5.46 (bs, IH), 5.12 
(s, 2H), 4.16 (m, 2H), 3.68 (s, 3H), 2.75-2.68 (m, 4H); ,3C NMR (90 MHz, CDCI3)
8  203.7,172.8, 156.1,136.2, 128.5,128.1, 128.0,67.0,51.9, 50.6,34.3,27.5.
(±>Methyl 5-(carboxybenzyl)-amino-4-oxo-hexanoate (74f)
60%, colorless oil; ‘H NMR (360 MHz, CDC13) 8  7.41-7.30 (m, 5H), 5.51 (bs, IH), 5.11 
(s, 2H), 4.43 (m, IH), 3.68 (s, 3H), 2.94-2.59 (m, 4H), 1.41 (d, 3H, J=  7.1 Hz); I3C NMR 
(90 MHz, CDCI3) 8  207.6,172.9,155.7,136.0, 128.5,128.1, 128.0,66.9,55.5, 51.8,
33.6, 27.5, 17.6.
(±)-Methyl 5-(carboxybenzyl)-ainino-6-methyl-4-oxobeptanoate (74g)
77%, colorless oil; *H NMR (360 MHz, CDCI3) 8  7.34-7.240 (m, 5H), 5.35 (d, IH, J= 
8.4 Hz)), 5.07 (s, 2H), 4.36 (dd, IH, J  = 3.8,8.4 Hz)), 3.65 (s, 3H), 2.92-2.52 (m, 4H), 
2.27-2.20 (m, IH), 1.01 (d ,3H ,J= 6 .7H z),0 .78(d ,3H ,J= 6 .7H z); l3C NMR (90 MHz, 
CDCI3) 8  207.5,173.0,156.7,136.4,128.7,128.4,128.3,67.2,64.6,52.0,35.6,30.5,
27.6,20.0,16.7.
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(±>Methyl 5-(carboxybenzyl)-amino-4-oxo-5-phenylpentanoate (74h)
48%, colorless oil; lH NMR (360 MHz, CDCh) 8  7.40-7.33 (m, 10H), 6.16 (bs, IH), 5.39 
(d, IH, J=  6.1 Hz), 5.10 (d, IH, J=  12.2 Hz), 5.01 (d, IH, J= 12.1 Hz), 3.67 (s, 3H), 
2.73-2.51 (m, 4H); l3C NMR (90 MHz, CDCI3) 8  204.0, 172.5, 155.5, 136.5, 136.2,
133.1,129.2, 128.7,128.5, 128.1, 127.9,66.9,64.5,51.8,34.3,27.6. HRMS (M+Hf 
calculated 356.1492, found 356.1491 for C20H21N 1O5 .
(±)-Methyl 5-(carboxybenzyl>amino-4-oxo-6-phenylhexanoate (741)
6 8 %, colorless oil; 'H  NMR (360 MHz, CDC13) 8  7.38-7.14 (m, 10H), 5.38 (d, IH, J= 
7.3 Hz), 5.08 (s, 2H), 4.64 (q, IH, J=  7.3 Hz), 3.67 (s, 3H), 3.16 (dd (A of AB), IH, J= 
6.4,14.1), 2.99 (dd (B of AB), IH, J=  6.9,14.1), 2.81-2.74 (m, 2H). 2.60-2.57 (m, 2H); 
13C NMR (90 MHz, CDCI3) 8  207.0, 173.0, 156.0, 136.2, 135.9, 129.2, 128.7, 128.5,
128.2,128.1,127.1,66.9,60.5,51.8,37.4,35.1,27.5. HRMS (M+Naf calculated
392.1468, found 392.1472 forC2iH23N,05Na.
Methyl 5-(N-benzoyl)-amino-4-oxo-pentanoate (74j)
58%, colorless oil; lH NMR (360 MHz, CDCI3) 8  7.83-77.5 (m, 2H), 7.55-7.41 (m, 3H),
6.93 (bs, IH), 4.42 (d, 2H, J=  4.5 Hz), 3.70 (s, 3H), 2.88-2.70 (m, 4H); 13C NMR (90 
MHz, CDCI3) 8  203.9, 172.8,167.2, 133.7, 131.7, 128.6,127.0,51.9,49.6,34.6,27.6.
(±)-Methyl 5-(N-benzoyl)-amino-4-oxo-hexanoate (74k)
58%, colorless oil; lH NMR (360 MHz, CDCI3) 8  7.82-7.79 (m, 2H), 7.53-7.42 (m, 3H),
7.02 (d, IH, J=  6.3 Hz), 4.85 (dq, IH, J=  7.0,7.0 Hz), 3.68 (s, 3H), 3.01-2.61 (m, 4H),
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1.52 (d, 3H, J=  7.1 Hz); 13C NMR (90 MHz, CDC13) 8  207.9, 173.0,166.6, 134.0,131.7,
128.5, 127.0,54.4, 51.9,33.8,27.6,17.6.
(±)-Methyl 5-(N-benzoyl)-aiiiino-4-oxo-5-plienylpenUnoate (740
43%, colorless oil; 'H  NMR (360 MHz, CDClj) 8  7.81 (m, 1H), 7.55-7.33 (m, 9H), 5.79 
(d, IH, J =6.1 Hz), 3.65 (s, 3H), 2.90-2.50 (m, 4H); l3C NMR (90 MHz, CDCI3) 8
204.6, 172.8, 166.5, 136.5, 133.9, 131.7,129.3, 128.7,128.5, 128.1, 127.1,63.3, 52.0,
34.5,27.7. HRMS (M+Na)+ calculated 348.1206, found 348.1199 for Cl9Hi9N 10 4Na.
(±)-Methyl 5-(N-benzoyl)-aniino-4-oxo-6-phenylhexanoate (74m)
58%, colorless oil; lH NMR (360 MHz, CDCI3) 8  7.72 (m, 2H), 7.51-7.20 (m, 8 H), 6.77 
(d, 1H, J  = 6 . 8  Hz), 5.07 (dt, 1H, J=  6 .6 , 6 . 6  Hz), 3.68 (s, 3H), 3.30 (dd, 1H / =  6.7,14.1 
Hz), 3.17 (dd, 1H, J=  6.5,14.3 Hz), 2.83 (dd, 2H, J=  5.0,5.1 Hz), 2.62 (dd, 2H, J = 5.1.
5.0 Hz)); 13C NMR (90 MHz, CDCI3) 8  206.8,173.2, 166.8,136.0, 133.9, 131.8, 129.3,
128.7.128.6, 127.1,126.9,59.3,51.9,37.2,35.2,27.6. HRMS (M+Na)+ calculated 
362.1363, found 362.1364 for C2oH2 iN,0 4 Na.
Methyl 5-(carboxy-9-fluorenylinethyl)-amino-4-oxo-pentanoate (74n)
55%, white sohd; mp = 75 -  78 °C: lH NMR (360 MHz, CDCI3) 8  7.75 (m, 2H), 7.60 (m, 
2H), 7.42-7.29 (m, 4H), 5.56 (bs, 1H), 4.40 (m, 2H), 4.27 (m, 1H), 4.15 (m, 2H), 3.68 (s, 
3H), 2.73-2.66 (m, 4H); 13C NMR (90 MHz, CDCI3) 8  204.0,172.8,156.2,143.9,141.3,
127.7,127.0,125.1,119.9,67.1, 52.2,50.6,47.1,34.3,27.5.
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(±)-Methyl 5-(carboxy-9-fluorenylmethyI)-amino-4-oxo-hexanoate (74o)
57%, white solid; mp = 95 -  97 °C: lH NMR (360 MHz, CDCI3) 5 7.77 (m, 2H), 7.60 (m, 
2H), 7.42-7.30 (m, 4H), 5.56 (bs, 1H), 4.45-4.35 (m, 3H), 4.22 (m, 1H), 3.68 (s, 3H), 
2.92-2.59 (m, 4H), 1.42 (d, 3H, 7 =  7.1 Hz); UC NMR (90 MHz, CDC13) 8  207.7,173.0,
155.8.144.0, 141.3,127.7, 127.0, 125.0, 120.0,66.8,55.5,51.9,47.1,33.7,27.5, 17.8.
(±)-MethyI 5-(carboxy-9-fluorenylmethyl)-aiiiino-4-oxo-5-phenylpentanoate (74p)
63%, white solid; mp = 110 -1 1 5  °C: lH NMR (360 MHz, CDCI3) 8  7.76 (m, 2H), 7.56 
(m, 2H), 7.41-7.21 (m, 9H), 6.21 (m, 1H), 5.41 (m, 1H), 4.40-4.29 (m, 2H), 4.21-4.17 (m, 




6 8 %, white solid; mp = 108-110 °C: lH NMR (360 MHz, CDCI3) 8  7.78 (m, 2H), 7.55 
(m, 2H), 7.42 (m, 2H), 7.31-7.24 (m, 5H), 7.16 (m, 2H), 5.48 (d, 1H, 7 =  7.8 Hz), 4.67 
(dt, IH, 7 =  7.6, 7.8 Hz), 4.43-4.33 (m, 2H), 4.21-4.17 (m, 1H), 3.68 (s, 3H), 3.19 (d, 1H, 
7 =  6.0,14.0 Hz), 3.00 (d, 1H, 7 =  7.5,14.0 Hz), 2.79-2.74 (m, 2H), 2.64-2.60 (M, 2H); 
l3C NMR (90 MHz, CDCI3) 8  206.8, 173.0,155.8, 143.7, 141.3,136.0, 129.2, 128.7,
127.7.127.1.127.0.125.0.120.0.66.9.60.5.51.9.47.1.37.3, 35.0,27.5. HRMS 
(M+H)+ calculated 458.1962, found 458.1938 for CaftsNiOs.
Benzyl (5S)-5-[(tert-butoxycarbonyl)amino]-4-oxohexanoate (75b)
40%, colorless oil: lH NMR (360 MHz, CDC13) 8  7.39-7.29 (m, 5H), 5.18 (m, 1H), 5.11
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(s, 2H), 4.33 (m, 1H), 2.92-2.62 (m, 4H), 1.44 (s, 9H), 1.33 (d, 3 H ,J=  7.1 Hz); l3C NMR 
(90 MHz, CDC13) 6 207.9,172.3,155.5,135.7, 128.5, 128.3, 1282 , 79.8,66.5,55.0,
33.6.28.3.27.8, 17.6.
Benzyl (5S)-5-[(tert-butoxycarbonyI)ainino]-4-oxo-5-phenylpentanoate (75c)
60%, colorless oil: lH NMR (360 MHz, CDC13) 8 7.39-7.26 (m, 10H), 5.87 (m, 1H),
5.33 (m, 1H), 5.08 (s, 2H), 2.81-2.50 (m, 4H), 1.41 (s, 9H); l3C NMR (90 MHz, CDCI3) 8
204.2, 172.0, 154.8, 136.8, 135.7,129.2, 128.5, 128.2, 128.1, 127.8,79.9,66.5,64.1,
34.3.28.3.27.9.
Benzyl (5S>5-[(tert-butoxycarbonyl)amino]-4-oxo-6-plienylliexanoate (75d)
55%, colorless oil: 'H NMR (360 MHz, CDCI3) 8 7.39-7.15 (m, 10H), 5.12 (s, 2H), 5.07 
(m, 1H), 4.53 (m, 1H), 3.14-3.08 (m, 1H), 2.96-2.90 (m, 1H), 2.84-2.61 (m, 4H), 1.40 (s, 
9H); 13C NMR (90 MHz, CDCI3) 8 207.4,172.3, 155.2, 136.2, 135.7, 129.2,128.6,
128.5, 128.2, 126.9,79.9,66.5,60.1,37.4,35.0,28.2,27.8.
Dibenzyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxoheptanedioate (75r)
lH NMR (360 MHz, CDCI3) 8 7.38-7.32 (m, 10H), 5.59 (d, 1H, J=  8.5 Hz), 5.11 (s, 4H), 
4.50 (m, 1H), 3.00-2.80 (m, 4H), 2.65 (m, 2H), 1.45 (s, 9H); l3C NMR (90 MHz, CDCI3) 
8 206.8, 172.3, 171.6, 155.5, 136.1, 135.5, 128.5, 128.4, 128.2,80.3,66.8,66.5,55.9,
35.6,33.7,28.3,28.0.
60
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Benzyl (5S)-5,9-bi3[(tert-butoxycarbonyI)ainino]-4-oxononanoate (75t)
69% colorless oil: lH NMR (360 MHz, CDCI3) 8  7.39-7.32 (m, 5H), 5.24 (d, 1H, J= 22  
Hz), 5.11 (s, 2H), 4.68 (bs, 1H), 4.29 (m, 1H), 3.11 (m, 2H), 2.92-2.61 (m, 4H), 1.60-1.26 
(m, 6 H), 1.44 (s, 18H); l3C NMR (90 MHz, CDCI3) 8  207.8, 172.4,156.2, 155.6, 135.8,
128.5, 128.4, 128.2, 80.0,79.2,66.5,59.0,39.8,34.2, 31.0,29.6,28.4,28.3,27.7,22.0.
(5S)-5-[(tert-butoxycarbonyl)amiiio]-4-oxohexanoic acid (77b)
Refer to preparation o f 78. 98%, white solid: lH NMR (360 MHz, CDCI3) 8  5.28 (bs, 
1H), 4.33 (m, 1H), 2.86-2.59 (m, 4H), 1.42 (s, 9H), 1.33 (d, 3H, J=  6 . 8  Hz); l3C NMR 
(90 MHz, CDCI3) 8  208.0, 177.6,155.3,79.9,54.9, 32.4,28.2,27.6,17.5.
N-((l SH-carbomethoxy-2-phenylethyl) (5S)-5-(carboxy-t-butyl)-aniino-4-oxo- 
hexanoamide (78)
Into a 10 mL round-bottomed flask containing 90 mg (0.26 mmol) 75b dissolved in 4 mL 
absolute EtOH was added 30 mg of 10% Pd(C). The reaction vessel was stoppered and 
thoroughly flushed with nitrogen, charged with hydrogen, and stirred under a balloon of 
hydrogen for 10 min. After checking by TLC to ensure starting material was consumed, 
the reaction was filtered through a 0.45 uM syringe filter and concentrated to give 65 mg 
(99%) of a white crystalline solid 77 which was dissolved in 4 mL anhydrous DMF. To 
this solution was added 53 mg (0.27 mmol) l-(3-dimethylaminopropyl)-3- 
ethylcarbodiimide hydrochloride (EDC), 37 mg (0.27 mmol) l-hydroxybenzotriazole 
hydrate (HOBt), 60 mg (0.27 mmol) L-phenylalanine methyl ester hydrochloride, and 37 
uL (0.27 mmol) triethylamine. The reaction was stirred overnight, after which 10 mL sat
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aq. NH4 CI solution was added and the reaction mixture extracted with 2 x 20 mL EtOAc. 
The combined organic portions were washed with IS mL sat NaHCOs and 2 x 15 mL 
H2O, dried with MgS0 4 , and concentrated under reduced pressure. Flash 
chromatography on silica using 40% EtOAc in hexanes yielded 99 mg (89 %) N-((1S)-1- 
carbomethoxy-2 -phenylethy 1) (5S)-5-(carboxy-t-butyl)-amino-4-oxo-hexanoamide 78 as a 
white solid; mp = 89 - 90 °C; !H NMR (360 MHz, CDCI3) 8  7.31-721 (m, 3H), 7.11- 
7.09 (m, 2H), 6.12 (d, 1H, J=  6.4 Hz), 5.25 (m 1H), 4.83 (m, 1H), 4.29 (m, 1H), 3.70 (s, 
3H), 3.14-3.00 (m, 2H), 2.91-2.71 (m, 2H), 2.50-2.41 (m, 2H), 1.43 (s, 9H), 1.32 (d, 3H, 
J=  7.16 Hz); 13C NMR (90 MHz, CDCI3) 8  208.5,171.9,171.0, 155.0,135.8, 129.2,
128.5,127.1, 79.9, 55.0,53.1,52.2, 37.8,33.8,29.4,28.3,17.6. HRMS (M+Naf 
calculated 429.1996, found 429. 2010 for CziHso^OfiNa.
Benzyl (4S)-4-tert-butoxycarbonyl-5-cyano-3-oxo-pentanoate (80)
10%, colorless oil: 'H NMR (360 MHz, CDCI3) 8  7.45-7.38 (m, 5H), 5.38 (d, 1H, 7 =  8.0 
Hz), 5.19 (s, 2 H), 4.45 (dt, 1H, J  = 7.8, 8.0 Hz), 3.68 (d, 1H, 7 =  16.0 Hz), 3.61 (d, 1H, J  
= 15.8 Hz), 2.94 (dd, IH, / =  5.2,17.1 Hz), 2.87 (dd, lH , /=  5.0,17.0 Hz), 1.45 (s, 9H ); 
13C NMR (90 MHz, CDCI3) 8  198.9,171.3,166.5,155.0,134.8, 128.7,128.6, 128.5,
81.8,67.5,55.9,45.3,28.1,19.2.
Benzyl N~2~(tert-butoxycarbonyl)-L-asparaginyl-L-alaninate (81)
In a 25 mL round bottomed flask was added 300 mg (1.29 mmol) L-48n and HOBt (174 
mg, 1.29 mmol) to a solution of H-(L)-Ala-OBn' HC1 (214 mg, 0.99 mmol) in 4 mL 
CH2CI2  containing Et3N (181 uL, 1.29 mmol). After a few minutes, the reaction becomes
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heterogenous and a solution of D C C (266 mg, 1.29 mmol) in 2 mL CH2CI2 was added. 
The reaction was stirred at room temperature overnight, cooled in an ice bath, and 
filtered. The filtrate was diluted with 10 mL EtOAc and washed with 10% citric acid, sat 
NaHCCb, and water before drying with MgS0 4  and concentrating. The solid crude 
product is vigorously stirred in 10 mL Et20 for lh  and the solid filtered to give 381 mg 
(75%) pure benzyl N~2~-(tert-butoxycarbonyl)-L-asparaginyl-L-alaninate 81 as a white 
solid; mp = 140 -141 °C; *H NMR (360 MHz, C D C b) 6 7.46-7.32 (m, 5H), 6.15-5.90 
(m, 2H), 5.40 (m, 1H), 5.20 (m, 2H), 4.62-4.45 (m, 2H), 2.90-2.85 (m, 1H), 2.60-2.53 (m, 
IH), 1.46 (s, 9H), 1.42 (d, 3H, J=  7.3 Hz); l3C NMR (90 MHz, CDCI3) 8 173.5,172.4,
171.0, 155.7,135.3, 128.6,128.4, 128.1,80.3,67.1,50.8,48.3,37.0,28.3,17.9.
N~2~(tert-butoxycarbonyI)-L-asparaginyI-L-alanine (82)
Into a 25 mL round bottomed flask was weighed 200 mg (0.50 mmol) benzyl N~2~-(tert- 
butoxycarbonyl)-L-asparaginyl-L-alaninate 81 and the flask charged with 10 mL absolute 
ethanol and 5 mL glacial acetic acid. Palladium on activated carbon 
(10 wt%, 30 mg) was added and the flask placed under a hydrogen atmosphere with a 
balloon for 15 minutes. After flushing the flask with nitrogen, the reaction mixture was 
filtered through a 0.45 uM syringe filter and concentrated to give 153 mg (99%) of 
N~2—(tert-butoxycarbonyl)-L-asparaginyl-L-alanine 82 as a white solid; mp = 203 - 204 
°C 'H NMR (360 MHz, CD3OD) 8 4.45-4.34 (m, 2H), 2.69-2.53 (m, 2H), 1.43 (s, 9H), 
1.39 (d, 3H, J=  7.2 Hz); I3C NMR (90 MHz, CD3OD) 8 175.7, 175.0, 173.8, 80.8,52.7,
48.2,38.3,28.6, 17.8.
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Benzyl (4S)-4-{[N~2~(tert-butoxycarbonyl)-L-asparaginyl]amino}-3-oxopentanoate
(83)
Into a 10 mL round-bottomed flask was weighed 148 mg (0.48 mmol) N~2—(tert- 
butoxycarbonyl)-L-asparaginyl-L-alanine 82 and the solid dissolved in 2 mL anhydrous 
DMF. Carbonyl diimidazole (CDI) 80 mg (0.48 mmol) was added and the solution 
stirred until gas evolution ceased (approximately IS minutes). In a separate 25 mL 
round-bottom flask which contained a solution of monobenzyl malonate (284 mg, 1.44 
mmol) in 10 mL of anhydrous THF was added 284 uL (0.72 mmol) of a 1M hexane 
solution of dibutylmagnesium at 0 °C. The clear, colorless solution was allowed to warm 
to room temperature. The acyl imidazole solution was transferred to the flask which 
contained the magnesium salt and the reaction was monitored by TLC. The solution was 
allowed to stir for 8  hours and quenched by the addition of 20 mL sat. aq. NH4CI 
solution. The solution was extracted three times with 20 mL EtOAc. The combined 
organics were washed with sat. NaHCOj, water, and brine before being dried with MgS04 
and concentrated. The colorless oil was placed on a high vacuum for 2h and then 
crystallization of the material was induced by the addition of a small amount of THF.
The crystalline material was pumped dry to yield 172 mg (81%) o f benzyl (4S)-4- 
{[N~2—(tert-butoxycarbonyl)-L-asparaginyl]amino}-3-oxopentanoate 83 as a white 
solid; mp = 173 -175  (decomp.) °C lH NMR (360 MHz, DMSO-D6) 8  8.30 (m, 1H), 
7.40-7.30 (m, 5H), 7.26 (m, 1H), 6.93-6.90 (m, 2H), 5.10 (s, 2H), 4.26-4.20 (m, 2H), 3.65 
(s, 2H), 2.43-2.32 (m, 2H), 1.35 (s, 9H), 1.17 (d, 3H, J = 6.9 Hz); l3C NMR (90 MHz, 
DMSO-D6 ) 8  203.2,171.7,171.4,167.2,155.2,135.8,128.4,128.0,127.9,78.2,65.9,
54.1,51.2,45.1,36.9,28.1, 15.3.
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Benzyl (5S)-5-{[N~2—(tert-butoxycarbonyI)-L-asparaginyl]ainino}-4-oxohexanoate 
(84)
A 25 mL round-bottomed flask was charged with 12 mL anhydrous CH2CI2 and 150 uL 
(1.82 mmol) o f methylene iodide added. The solution was cooled to 0 °C and 1.20 mL 
(1.20 mmol) o f a IM solution of diethylzinc in hexanes was added slowly. The ice bath 
was removed and a white precipitate formed rapidly. After stirring for two minutes, 106 
mg (0.24 mmol) of solid benzyl (4S)-4- {[N~2~-(tert-butoxycarbonyl)-L- 
asparaginyljamino} -3 -oxopentanoate 83 was added in one portion and the reaction stirred 
2 minutes. The reaction was diluted with 20 mL CH2CI2 and quenched with 25 mL sat. 
aq. NH4CI solution. The organic portion was dried with MgS0 4 , filtered, and evaporated 
under reduced pressure. Column chromatography on silica using 1 0 % MeOH/CTfcCh 
yielded 70 mg (64%) benzyl (5S)-5- {[N~2—(tert-butoxycarbonyl)-L-asparaginyl]amino} - 
4-oxohexanoate 84 as a colorless oil; 'H NMR (360 MHz, CDCI3) 8  7.38-7.28 (m, 5H), 
6.11 (m, 1H), 5.74 (m, 1H), 5.10 (s, 2H), 4.54-4.49 (m, 2H), 2.91-2.55 (m, 6 H), 1.45 (s, 
9H), 1.34 (d, 3H ,y=  7.2 Hz); ,3C NMR (90 MHz, CDCI3) 8  207.1, 173.4, 172.3,171.1,
155.7,135.7, 128.5,128.3,128.2,80.3,66.5,54.2,51.0,36.9,33.6,28.3,27.7,16.9.
(5S)-5-{[N~2—(tert-butoxycarbonyI)-L-asparaginyl]amino}-4-oxohexanoic acid (85)
Into a 10 mL round bottomed flask was weighed 70 mg (0.15 mmol) benzyl (5S>5- 
{[N~2—(tert-butoxycarbonyl)-L-asparaginyl] amino} -4-oxohexanoate 84 and the flask 
charged with 3 mL absolute ethanol and I mL glacial acetic acid. Palladium on activated 
carbon ( 1 0  wt%, 1 0  mg) was added and the flask placed under a hydrogen atmosphere 
with a balloon for 15 minutes. After flushing the flask with nitrogen, the reaction mixture
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was filtered through a 0.45 uM syringe filter and concentrated to give 55 mg (99%) of 
(5S)-5-{[N~2~-(tert-butoxycarbonyl)-L-asparaginyl]amino}-4-oxohexanoic acid 85 as a 
white solid; *H NMR (360 MHz, CD3OD) 8  4.42 (m, 2H), 2.85-2.52 (m, 6 H), 1.43 (s, 




Into a 10 mL round-bottomed flask containing 14 mg (0.09 mmol) L-alanine methyl ester 
hydrochloride and 18 uL (0.12 mmol) triethylamine in 5 mL CH2CI2 was added 46 mg 
(0.12 mmol) (5S)-5-{[N~2~-(teit-butoxycarbonyl)-L-asparaginyl]amino}-4-oxohexanoic 
acid 85 and 18 mg (0.12 mmol) hydroxybenzotriazole hydrate. The mixture was stirred 
10 minutes and 27 mg (0.12 mmol) dicyclohexylcarbodiimide was added before stirring 
the reaction overnight The reaction was cooled to 0 °C and filtered through a 0.45 uM 
syringe filter before diluting with 10 mL CH2CI2 and washing with 10 mL sat. citric acid, 
10 mL sat. NaHC03 and 10 mL H2O. The organic portion was dried with MgS(> 4  and 
concentrated before chromatographing on silica using 10% MeOH/ CH2CI2 to yield 35 
mg (60%) benzyl N-((5 S)-5-{[N~2~-(tert-butoxycarbonyl)-L-asparaginyl]amino} -4- 
oxohexanoyl)-L-alaninate 8 6  as a white solid; mp = 195 -198 °C 'H  NMR (360 MHz, 
CDCVCD3OD) 6  8.09 (m, 2H), 6.56 (m, 1H), 4.46-4.38 (m, 3H), 3.73 (s, 3H), 2.92-2.73 
(m, 2H), 2.67 (d, 2H, J=  5.8 Hz), 2.59-2.47 (m, 2H), 1.46 (s, 9H), 1.39 (d, 3H, J=  7.3 
Hz), 1.36 (d, 3H, J=  7.2 Hz); I3C NMR (90 MHz, CDClj/CDjOD) 8  207.7,173.1,172.2, 
171.4, 155.4, 79.4,53.7,51.3,50.7,47.7,36.4,33.0,28.2,27.2, 16.1, 15.1.
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General Procedures for rhgmfatrv on Solid Supports
The chemistry was conducted on a Wang Resin available from Aldrich of a loading (that 
is, the amount of active sites available on the resin when it is swelled in the appropriate 
nonpolar solvent prior to reaction) indicated on the label as being “0.5-1.0 mmol/g”, but 
found in practice to be a maximum of 0.6 mmol/g. Following the workup of each 
reaction, the beads were thoroughly rinsed with solvent. The beads were dried on the frit 
of the reaction tube then placed under a high vacuum overnight. Loading of the resin was 
determined by taking 50 mg of dried resin and swelling in 1 mL methylene chloride for 5 
minutes. Two ml of TFA was added and the resin gently stirred with a stirbar for 15 
minutes before filtering off the resin, concentrating the solvent, and weighing the 
resulting TFA salt. The beads were stored on the lab bench in an ambient atmosphere. 
The resin was protected from physical damage by avoiding the grinding of the beads 
between hard surfaces and by avoiding repeated cycles of washing with solvents having 
different swelling properties (e.g. washing the resin with methanol, then methylene 
chloride repeatedly).
p-Nitrophenyloxycarbonyl Resin (87)
A sample o f 1.66 g p-hydroxybenzyloxy alcohol 1% crosslinked polystyrene resin in a 25 
mL reaction tube was stirred in 10 mL of 9:1 CffcCh-pyridine with 0.50 mL of 
diisopropylethyl amine and 0.60 g (approximately 3 equiv.) of 4-nitrophenyl 
chloroformate was added. After agitation for 24 h the resin was filtered through the frit 
of the reactor tube. The beads were washed three times with DMF, three times with
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CH2CI2 and dried in vacuo overnight to give 1.70 g of orange-brown 4- 
nitrophenyloxycarbonyl resin 87.
Resin-bound (D, L>phenylalanine allyl ester (88)
Into a 10 mL reaction tube was weighed 1.00 g dried p-nitrophenyloxycarbonyl resin and 
the resin swelled in 5 mL DMF. To the solution was added 0.675 g (approx. 2 equiv.) 
phenylalanine allyl ester p-toluenesulfonate and 0.440 mL (approx. 3 equiv.) 
diisopropylethyl amine and the suspension agitated overnight. The resin was washed 
three times with DMF, three times with CH2CI2, and dried in vacuo overnight to give 
1.30g of 88. Cleavage o f material from the resin by treatment with TFA revealed a 
loading of 0.57 mmol/g; lH NMR (360 MHz, CDCI3) 8 7.32-7.16 (m, 5H), 5.78 (tdd, 1H, 
J  = 6.1,10.5,17.1 Hz), 5.27 (d, 1H, J=  5.8 Hz), 5.23 (s, 1H), 4.56 (d, 2H, J=  5.9 Hz), 
4.23 (m, 1H), 3.26 (d, 2H, J=  6.2 Hz).
Resin-bound (D,L)-phenylalanine (89)
Into a 10 mL reaction tube was weighed 1.10 g o f 77 and the vessel charged with 5 mL 
dry THF. To the solution was added 1 mL morpholine and 80 mg tetrakis 
(triphenylphosphine) palladium (0) and the reaction agitated for 3 h. The resin was 
filtered, washed 3 times with THF, three times with DMF, and three times with CH2CI2 . 
The resin was sucked dry through a frit before drying in vacuo overnight to yield 0.92 g 
89. The loading was determined to be 0.53 mmol/g after TFA cleavage; ’HNM Rof 
TFA salt (360 MHz, CD3OD) 8 7.38 (m, 5H), 4.23 (m, 1H), 3.28-3.18 (m, 2H).
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Resin-bound benzyl (D,L)-5-(amino)-4-oxo-6-plienylhexanoate (90)
Into a 5 mL reaction tube containing 106 mg of 89 was added 3 mL THF and the resin 
allowed to swell IS minutes and drained. After resuspending the resin in 1 mL THF, 150 
mg carbonyldiimidazole was added and the vessel agitated 1.5 h. The THF was drained 
and the resin washed with three 2 mL portions of THF before suspending the swelled 
resin in 1 mL THF. To the solution was added a solution of 189 mg monobenzyl 
malonate in 3 mL THF to which 486 uL dibutylmagnesium was added at 0 °C. The 
reaction tube was agitated 8 h before the THF was drained off and the resin rinsed with 2 
X 4 mL THF, 2 X 3 mL 5% AcOH in THF, 2 X 3 mL 50/50 THF/H20 , 2 X 3 mL THF, 
and 2X 3  mL CH2CI2 . The resin was sucked dry on the frit before drying in vacuo 
overnight to give 190 mg of 90 as the dried resin. The loading was determined to be 0.46 
mmol/g after TFA cleavage; *H NMR (360 MHz, CDCI3) 6 7.37-7.15 (m, 5H), 5.11 (s, 
2H), 4.68 (bs, 1H), 3.51 (bs, 2H), 3.22-3.06 (m, 2H).
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APPENDIX: NMR SPECTRA
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